WO2004080582A2 - Ester polyols as solvents, and emulsions and dispersions containing the same - Google Patents

Ester polyols as solvents, and emulsions and dispersions containing the same Download PDF

Info

Publication number
WO2004080582A2
WO2004080582A2 PCT/EP2004/002385 EP2004002385W WO2004080582A2 WO 2004080582 A2 WO2004080582 A2 WO 2004080582A2 EP 2004002385 W EP2004002385 W EP 2004002385W WO 2004080582 A2 WO2004080582 A2 WO 2004080582A2
Authority
WO
WIPO (PCT)
Prior art keywords
polyols
polyol
este
phase
average
Prior art date
Application number
PCT/EP2004/002385
Other languages
German (de)
French (fr)
Other versions
WO2004080582A3 (en
Inventor
Stefan Günter BORCHERT
Gerd Dahms
Rolf-Dieter Petersen
Original Assignee
Clr-Chemisches Laboratorium Dr. Kurt Richter Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clr-Chemisches Laboratorium Dr. Kurt Richter Gmbh filed Critical Clr-Chemisches Laboratorium Dr. Kurt Richter Gmbh
Publication of WO2004080582A2 publication Critical patent/WO2004080582A2/en
Publication of WO2004080582A3 publication Critical patent/WO2004080582A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/34Higher-molecular-weight carboxylic acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/12Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
    • C08G63/16Dicarboxylic acids and dihydroxy compounds
    • C08G63/20Polyesters having been prepared in the presence of compounds having one reactive group or more than two reactive groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66Polyesters containing oxygen in the form of ether groups
    • C08G63/668Polyesters containing oxygen in the form of ether groups derived from polycarboxylic acids and polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/685Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen
    • C08G63/6854Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen derived from polycarboxylic acids and polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/017Mixtures of compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/017Mixtures of compounds
    • C09K23/018Mixtures of two or more different organic oxygen-containing compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2093Esters; Carbonates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00Properties
    • C08L2201/50Aqueous dispersion, e.g. containing polymers with a glass transition temperature (Tg) above 20°C
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00Properties
    • C08L2201/52Aqueous emulsion or latex, e.g. containing polymers of a glass transition temperature (Tg) below 20°C
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/72Ethers of polyoxyalkylene glycols
    • C11D1/721End blocked ethers

Definitions

  • the invention relates to the use of este polyols as solvents or solubilizers for organic compounds which are insufficiently soluble or insoluble in lipophilic and hydrophilic media and as dispersants for (micro) pigments.
  • the invention further relates to este polyol / polyol-in-oil emulsions (EP / O emulsions) containing este polyols, processes for their preparation, ester polyol / polyol-in oil in water emulsions (EP / O / W) containing these emulsions Emulsions), their
  • compositions and compositions of this type Use in cosmetic and / or pharmaceutical and / or detergent technology and / or food technology and / or agricultural technology active ingredient compositions and compositions of this type.
  • emulsions with active ingredients are often used, with which suitable compositions can be produced for the desired form of use.
  • the production of polyol-in-oil emulsions and polyol-in-oil-in-water emulsions is known per se.
  • Such emulsions can be used to convert cosmetic and / or pharmaceutical active ingredients into a form suitable for use.
  • DE-A-43 41 114 relates to anhydrous X / O emulsions which contain a non-aqueous, oil-immiscible phase and an oil phase.
  • an active ingredient which can also be in the form of a solid, can be present for medical, cosmetic or technical applications, for example.
  • the emulsion is made using a special emulsifier that has a maximum HLB of 6 or is a W / O emulsifier.
  • Propylene glycol, butylene glycol, polyalkylene glycol, glycerin, polyglycerol and mixtures thereof are mentioned as usable polyol.
  • DE-A-43 41 113 relates to a stable multiple emulsion of the X / O / Y type.
  • X is an oil-immiscible component
  • O oil phase
  • Y an aqueous phase.
  • W / O / W emulsions and P / O / W emulsions are described in particular, it being possible in turn to use propylene glycol, butylene glycol, polyalkylene glycol, glycerin, polyglycerol or mixtures thereof as the polyol phase.
  • the object of the present invention is to provide cosmetically, pharmaceutically and agrotechnologically compatible solubilizers for active ingredients which are insufficiently soluble or insoluble in hydrophilic and lipophilic media.
  • polyol-in-oil emulsions are to be provided with a novel polyol substitute component, the substitute component being able to act as a solubilizer for the active ingredients.
  • the aim is to remedy the disadvantages of the known active substance formulations.
  • Alternative solid lipid nanoparticle (SLN) systems are also to be made available.
  • ester polyols which differ from
  • Glycerol C 2-20 alkylene glycol, preferably C -10 alkylene glycol, especially C 2-8 alkylene glycol, for example propylene glycol, butylene glycol and especially ethylene glycol, poly (C 2-20 alkylene) glycol, preferably poly (C 2- 10- alkylene) glycol, in particular poly (C 2- 8 alkylene) glycol, with one or more different alkylene radicals, for example polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, polyglycerols, sorbitol, pentaerythritol as the polyol component and
  • este polyols with uri-functional polyols with a melting point of less than 100 ° C or este polyols of the general formula (I) R'-O-I ⁇ O-PO- R 2
  • R is hydrogen or C 1-4 alkyl, n on average 1 to 100, m on average 0 to n / 2
  • the este polyols which are used according to the invention are derived from polyol components and acid components which are esterified with one another.
  • Glycerol, ethylene glycol, polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, and mixtures thereof are used as the polyol component.
  • the polyethylene glycol preferably contains 1 to 600, particularly preferably 1 to 100, ethyleneoxy units.
  • Aliphatic C 3-6 carboxylic acids are used as the acid component which, in addition to a carboxyl group, have at least one further functional group selected from hydroxyl and carboxyl groups.
  • the carboxylic acids preferably contain only carbon, hydrogen and oxygen as atoms.
  • the carbon chain can be free of double bonds or contain a double bond.
  • suitable acid components are lactic acid, maleic acid, tartaric acid and citric acid.
  • esterified in the este polyols may be esterified in the este polyols.
  • carboxyl groups of the acid component can be in ester form.
  • the este polyols used according to the invention can be in solid, glass-like, viscous or liquid form at room temperature (25 ° C.). The properties can be specifically adjusted by mixing several este polyols. For example, lactates are usually in liquid form, while citrates are in a glass-like state and only become viscous at a temperature of around 50 ° C. A 1: 1 mixture of citrate and lactate is similar to glass. In contrast, a mixture of citrate and lactate in a weight ratio of 1: 2 is viscous.
  • the este polyols are often crystal clear and solid at room temperature.
  • the este polyols can be used in combination with amino-functional polyols, ether alcohols or both compounds.
  • the proportion of este polyols in such mixtures is preferably at least 10% by weight, particularly preferably at least 15% by weight, in particular at least 20% by weight.
  • amino-functional polyol which has a melting point of less than 100 ° C., preferably less than 50 ° C., can be used as the amino-functional polyol.
  • amino-functional polyols means that there is at least one amine group or amide group in the polyol.
  • the polyol also has at least two hydroxyl groups. It can be an aliphatic, aromatic or aromatic / aliphatic polyol. It is preferably an aliphatic polyol.
  • the polyol particularly preferably contains 2 to 10, particularly preferably 2 to 5, in particular 2 to 3, hydroxyl groups.
  • the amino-functional polyols can have carbonyl groups, carboxyl groups, thiol groups and carbon-carbon double bonds or triple bonds. They can also have ether groups. Some of the hydroxyl groups present in the molecule can be etherified, provided that at least two free hydroxyl groups are present in the molecule.
  • the amino-functional polyols used according to the invention preferably contain one or two amide groups.
  • amino-functional polyols which have two or three hydroxyl groups and one or two amide groups. They can also have an additional thiol group or carboxyl group.
  • the compounds preferably contain 5 to 15 carbon atoms, particularly preferably 7 to 12 carbon atoms.
  • the amino-functional polyol is preferably a pantothene derivative of the general formula (II) HO-CH 2 -C (CH 3 ) 2 -CH (OH) -CO-NH-CH 2 -CH 2 -R
  • R 1 H Ci.u-Al yl, phenyl.
  • R is preferably a CH 2 -OR 1 radical.
  • R 1 is preferably hydrogen or C 1-6 alkyl, in particular hydrogen or C 1-3 alkyl.
  • Pantothenic acid, panthenol or panthetein are particularly preferably used.
  • the pantothene derivatives are preferably in the (R) form.
  • Pantothenic acid can also be used in the form of the salts, the pantothen derivative (R) - panthenol being particularly preferred.
  • the compounds preferably used according to the invention have a molecular segment which is derived from pantoic acid, and a molecular segment which is derived from ⁇ -alanine, provided that it is a compound comparable to pantothenic acid.
  • Panthenol and pantothenic acid are known from the medical field for wound healing as well as from hair treatment agents and feed additives.
  • the preparation can be carried out via biosynthesis from 2-oxo-3-methylbutanoic acid or from pantolactone. Other manufacturing processes are generally known.
  • pantothen derivatives in particular panthenol, in cosmetic and pharmaceutical compositions.
  • Basic building blocks derived from ethylene oxide and optionally additionally from propylene oxide can be present in the este polyols of the general formula (I). These basic building blocks have the structures -CH 2 -CH 2 -O-, -CH 2 -CH (CH 3 ) -O- and -CH (CH 3 ) - CH 2 -O-. If the two basic building blocks derived from ethylene oxide and propylene oxide are present, they can be in any order. This means that one or more blocks derived from ethylene oxide and propylene oxide can be connected to one another. The units derived from ethylene oxide and propylene oxide can also be present alternately or statistically. The continuous transitions possible between these forms are also possible according to the invention.
  • the proportion of the basic building blocks derived from propylene oxide is at most a fraction of the amount of basic building blocks derived from ethylene oxide. While on average 1 to 100, preferably 2 to 70, particularly preferably 3 to 50, in particular 5 to 15, of ethylene oxide derived basic building blocks are present, there are 0 to n 2, preferably 0 to n / 4, particularly preferably 0 to n / 8 basic building blocks derived from propylene oxide. If basic building blocks derived from propylene oxide are present, their amount is preferably n / 10 to n / 4, particularly preferably n / 8 to n / 5.
  • n and m are average values, since the alkoxylation range generally results in a distribution of the degree of alkoxylation. Therefore, odd-numbered values for n and m are also possible.
  • the breadth of the distribution of the degree of alkoxylation also depends, inter alia, on the alkoxylation catalyst used. It is also possible to set discrete degrees of alkoxylation or very narrow distributions of the degree of alkoxylation.
  • R 1 is a C 1-4 alkyl radical, preferably C 1-3 alkyl radical, particularly preferably C 1- alkyl radical, in particular a methyl radical.
  • Propyl residues include n-propyl and iso-propyl, while butyl residues include n-butyl, iso-butyl, tert-butyl.
  • R represents hydrogen or a radical as defined for R above.
  • the meaning of R 2 is independent of the meaning of the radical R 1 .
  • R 2 is particularly preferably hydrogen.
  • Estolyol used in the description and the claims includes all compounds of the general formula (I), ie also the cases in which R 2 is not a hydrogen atom and thus there are no free hydroxyl groups in the molecule.
  • the este polyol is preferably a methanol ethoxylate with 5 to 15 ethylene oxide units.
  • Polyethylene glycol monomethyl ether (12EO) and polyethylene glycol monomethyl ether (7EO) are particularly preferably used. These are pure methyl alcohol ethoxylates. Such compounds are known per se and have hitherto been used for the preparation of methyl end groups
  • Fatty acid polyethylene glycol esters used.
  • the connections are commercially available.
  • este polyols of the general formula (I) which are liquid at room temperature (25 ° C.).
  • the corresponding carrier phase is thus either formed only by the ester polyols of the general formula (I), or there are mixtures of the ester polyols with polyols, ether alcohols or amino-functional polyols.
  • organic or inorganic compounds may be present in the ester polyol / polyol phase.
  • este polyol / polyol phases can be present in the este polyol / polyol-in-oil emulsions (EP / O emulsions) according to the invention.
  • an este polyol / polyol phase which contains at least one este polyol as described above.
  • At least 10 or at least 50% by weight, particularly preferably at least 80% by weight, in particular at least 95% by weight, of the este polyol are preferably present in the polyol phase, based on the total este polyol / polyol phase.
  • este polyol / polyol phase water may also be present in an amount of at most 20% by weight, preferably at most 10% by weight, in particular at most 5% by weight, based on the total estepolyol / polyol phase.
  • the este polyol / polyol phase is preferably largely or completely anhydrous.
  • the sum of este polyol, optionally ether alcohol, amino-functional polyol, other polyol and water is 100% by weight.
  • the customary known polyols such as propylene glycol, butylene glycol, ethylene glycol, polyalkylene glycol, glycerol, polyglycerol, glycosides, sorbitol, mannitol, pentaerythritol, trimethylolpropane or mixtures thereof can be present as polyols.
  • Polyalkylene glycols in particular include polyethylene glycol and polypropylene glycol.
  • Other suitable polyols are known to the person skilled in the art, for example aromatic polyols such as Emodin / Aloe Vera. These polyols can also be the basis of the above este polyols.
  • esteolyols as described above are present in the estepholyol / polyol phase.
  • the este polyol / polyol phase is not miscible with oil.
  • the EP / O emulsions according to the invention preferably no estepolyol / polyol dissolves in the oil phase or oil dissolves in the estepolyol / polyol phase. Minor deviations from this (about up to 5% by weight, preferably up to about 1% by weight, in particular up to about 0.5% by weight of solubility) are irrelevant here. It depends on the fact that in the EP / O emulsion an emulsion of the este polyol / polyol phase is obtained in the oil phase and not a solution of the este polyol / polyol in the oil.
  • suitable oils and their mixtures can be used as oil in the oil phase.
  • suitable oils are silicone oils and derivatives thereof, which can be linear or cyclic, natural ester oils such as grape seed oil, olive oil or sunflower oil, synthetic ester oils such as neutral oils, which can be linear or branched, paraffin oils and isoparaffin oils, ester oils, for example the citrates, lactates, aleates , Salicylates, cinnamates or other organic light protection filters, or of camphor derivatives, triglycerides, fatty alcohols or mixtures thereof.
  • the weight ratio of estepolyol / polyol phase to oil phase is preferably 10:90 to 90:10, particularly preferably 25:75 to 75:25 and in particular 40:60 to 60:40.
  • emulsifiers which are suitable for producing an emulsion of the este polyol / polyols in oil can be used as emulsifiers.
  • suitable emulsifiers are glycerol esters, polyglycerol esters, sorbitan esters, sorbitol esters, fatty alcohols, propylene glycol esters, alkyl glucose esters, sugar esters, lecithin, silicone copolymers, wool wax and mixtures or derivatives thereof.
  • Glycerol esters, polyglycerol esters, alkoxylates and fatty alcohols and iso alcohols can be derived, for example, from castor fatty acid, 12-hydroxystearic acid, isostearic acid, oleic acid, linoleic acid, linolenic acid, stearic acid, myristic acid, lauric acid and capric acid.
  • succinates, amides or ethanolamides of the fatty acids can also be present.
  • Suitable fatty acid alkoxylates are, in particular, the ethoxylates, propoxylates or mixed ethoxylates / propoxylates.
  • the amount of emulsifier can be adapted to practical requirements.
  • the emulsifier is preferably used in an amount of 0.1 to 20% by weight, particularly preferably 0.5 to 15% by weight, in particular 1 to 8% by weight, based on the entire EP / O emulsion , In some cases, different doses may be necessary.
  • the este polyol / polyol phase or the este polyol solution or dispersion can contain a cosmetic and / or pharmaceutical active ingredient or perfume, perfume oils or aromas dissolved in the phase. It can also be a detergent technology, food technology technology or agricultural technology (agro) active ingredient.
  • the active substances are preferably organic compounds which are insufficiently soluble, in particular insoluble, in lipophilic and hydrophilic media. The compounds are insufficiently soluble or insoluble, especially in water and oil.
  • Any suitable active ingredients can be used, provided they dissolve in the este polyol or the este polyol / polyol phase containing the este polyol. Suitable active ingredients are, for example, dichlophenac, ibuprofen, acetylsalicylic acid, salicylic acid, erythromycin, ketoprofen, cortisone, glucocorticoids.
  • cosmetic active ingredients that are particularly sensitive to oxidation or hydrolysis, such as polyphenols.
  • Catechins such as epicatechin, epicatechin-3-gallate, epigallocatechin, epigallocatechin-3-gallate
  • flavonoids such as luteolin, apigenin, rutin, quercitin, fisetin, kaempherol, rhametin
  • isoflavones such as genistein, glycine, daidzein
  • Prunetin coumarins (such as daphnetin, umbelliferon), Emodin, Resveratrol, Oregonin.
  • Vitamins such as retinol, tocopherol, ascorbic acid, riboflavin, pyridoxine are suitable.
  • total extracts from plants that include contain the above molecules or classes of molecules.
  • the active ingredients are light protection filters. These can be in the form of organic light protection filters at room temperature (25 ° C) in liquid or solid form. Suitable light protection filters (UV filters) are, for example, compounds based on benzophenone, diphenyl cyanoacrylate or p-aminobenzoic acid.
  • organic light protection filters are octyl triazone, avobe zone, octyl methoxy cinnamate, octyl salicylate, benzotriazole and triazine.
  • the este polyols can also be used as solubilizers and / or dispersants for antidandruff agents.
  • anti-dandruff active ingredients such as are usually present in cosmetic or pharmaceutical formulations are used as active ingredients.
  • An example of this is piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-dimethylpentyl) -2 (1H) -pyridone; preferably in combination with 2-aminoethanol (1: 1)).
  • Other suitable agents for the treatment of skin flakes are known to the person skilled in the art.
  • organic dyes are used as active substances or instead of active substances.
  • any suitable amounts of the active ingredient can be introduced into the ester polyol / polyol phase.
  • the amount that can be introduced is often determined by the solubility and the ultimate field of application of the preparation.
  • 0.01 to 95% by weight, preferably 0.1 to 80% by weight, in particular 2 to 50% by weight, of the active ingredient are introduced into the estepolyol or the estepolyol / polyol phase
  • the proportion by weight refers to the sum of active ingredient and este polyol / polyol.
  • the stated proportion by weight of estepolyol / polyol can be replaced by the active ingredient.
  • the EP / O emulsion or dispersion described above can also be emulsified in water or a water-in-oil emulsion.
  • the result is an este polyol / polyol in oil in water emulsion (EP / O / W emulsion) which contains at least one emulsion as described above and additionally at least one aqueous phase.
  • the structure of such multiple emulsions can correspond to the emulsions described in DE-A-43 41 113, the polyol component being varied in the manner according to the invention.
  • the structure of the Este ⁇ olyol / polyol-in-oil emulsion can be the structure of the in DE-A-43 41 114 correspond to the emulsions described, the este polyol / polyol phase according to the invention being used as the polyol phase.
  • the weight ratio of the individual phases can be varied within wide ranges.
  • the weight fraction of the EP / O emulsion is preferably 0.01 to 80% by weight, particularly preferably 0.1 to 70% by weight, in particular 1 to 30% by weight. %, based on the total EP / O / W emulsion.
  • the proportion of the EP / O emulsion is preferably 0.01 to 60% by weight, particularly preferably 0.1 to 40% by weight, in particular 1 up to 30% by weight, based on the EP / O / W emulsion ultimately obtained.
  • the oil content is preferably 1 to 80% by weight, particularly preferably 1 to 30% by weight, based on the O / W emulsion used.
  • the individual phases of the emulsions can also have the usual ingredients known for the individual phases.
  • the individual phases can contain further pharmaceutical or cosmetic active ingredients that are soluble in these phases.
  • the aqueous phase can contain, for example, organic soluble light protection filters, hydrophilically coated micropigment, electrolytes, alcohols, etc. Some or all of the phases can also contain solids, which are preferably selected from pigments or micropigments, microspheres, silica gel and similar substances.
  • the oil phase can contain, for example, organically modified clay minerals, hydrophobically coated (micro) pigments, organic oil-soluble light protection filters, oil-soluble cosmetic active ingredients, waxes, metal soaps such as magnesium stearate, petroleum jelly or mixtures thereof.
  • Titanium dioxide, zinc oxide and barium sulfate, as well as wollastonite, kaolin, talc, Al 2 O 3 , bisnut oxide chloride, micronized polyethylene, mica, ultramarine, eosin dyes, azo dyes, can be mentioned as (micro) pigments.
  • titanium dioxide or zinc oxide are used in cosmetics as light protection filters and can be applied to the skin particularly smoothly and evenly by means of the emulsions according to the invention.
  • Microspheres or silica gel can be used as carriers for active ingredients, and waxes can be used, for example, as the basis for polishes.
  • the este polyols according to the invention can also be used as dispersing agents or continuous phase for (micro) pigment dispersions.
  • Systems of this type consisting of este polyols and (micro) pigments according to the invention typically contain 10 to 50% by weight of (micro) pigments, particularly preferably 35 to 45 % By weight of (micro) pigments.
  • the dispersions obtainable from the (micro) pigments and the este polyols can be introduced in water or in oil without the dispersion being adversely affected. It is thus possible, by using the este polyols, to make hydrophilic pigments hydrophobic and to introduce them into an oil phase without the degree of dispersion deteriorating.
  • the invention thus also relates to a dispersion of (micro) pigments and / or insoluble organic compounds in este polyols.
  • the water phase can also contain glycerol, polyethylene glycol, propylene glycol, ethylene glycol and similar compounds and derivatives thereof.
  • drugs which are administered orally but which are not stable under the conditions prevailing in the stomach or which are intended to act in other places on the digestive tract can be brought to their place of action with an emulsion according to the invention.
  • This emulsion or dispersion is not broken in the stomach, so that it passes through the stomach unchanged.
  • the active ingredient contained is therefore only subsequently released in the digestive tract by breaking down or dissolving the emulsifier.
  • the choice of emulsifiers can be adjusted to the conditions existing at the sites of action.
  • the EP / O emulsions or dispersions according to the invention can be prepared by known processes, as described, for example, in DE-A-43 41 114 and DE-A-43 41 113.
  • the este polyol / polyol phase and the oil phase which can each contain emulsifier, are usually heated separately to a temperature in the range from 20 to 90 ° C. and then combined with stirring.
  • the emulsions or dispersions can be prepared and present as solid or flowable emulsions or dispersions, depending on the composition, the phase volume ratio and the solids content which may be present. These are very stable emulsions or dispersions that have high long-term stability under normal handling conditions. In particular, they meet the usual stability requirements in the temperature range from -5 ° C to + 45 ° C.
  • the droplets or particles present in the emulsion or dispersion are very stable, which is why the emulsions or dispersions are particularly suitable as carriers for many types of active ingredients.
  • the emulsions or dispersions prepared with the aid of the emulsifiers mentioned can be obtained by a simple mixing process with stirring, the stability of the emulsions or dispersions generally being hardly or not influenced by the agitator energy input and the type of stirring tool. Any suitable commercially available stirrer can be used to produce the emulsion or dispersion according to the invention.
  • the invention also relates to an Este ⁇ lyol-in-oil dispersion containing Este ⁇ olyolparticles in oil as a dispersant, which are derived from glycerol, ethylene glycol, polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, as a polyol component and aliphatic C 3 _ 6 - carboxylic acids, which in addition to a carboxyl group have at least one further functional group selected from hydroxyl and carboxyl groups, are derived as acid components which are solid or glassy at 25 ° C., with an average particle size in the range from 10 to 10,000 nm, at least an emulsifier which forms lamellar structures, the estepolyol particles being able to contain a pharmaceutical, cosmetic, detergent-technological, food-technological and / or agricultural-technological active ingredient dissolved or dispersed in the phase.
  • a dispersant which are derived from glycerol,
  • This dispersion is in particular an SPN dispersion (solid polyol nanoparticles) analogous to an SLN dispersion (solid lipid nanoparticles), the lipid phase being replaced in whole or in part by the solid este polyols used in accordance with the invention and working in oil instead of water.
  • SPN dispersion solid polyol nanoparticles
  • solid lipid nanoparticles solid lipid nanoparticles
  • the structure and production of the SPN dispersion according to the invention is described, for example, in EP-B 0 605 497 and EP-B 0 167 825.
  • the dispersion can be prepared as described there, and the dispersion can contain the pharmaceutically active substances described.
  • the dispersion is produced by mechanical mixing of the este polyol phase with an oil phase at a temperature above the melting or softening point of the este polyol, the weight ratio of este polyol phase to oil phase being 1: 5 to 5: 1, preferably 2: 1 to Is 1: 2.
  • the mixing is preferably carried out without high-pressure homogenization using stirrers in which the shear effect corresponds to the shear effect of a household stirrer.
  • the mixed phase thus obtained can then be further diluted with oil until a desired degree of dispersion is achieved.
  • Emulsifiers suitable for the preparation of the dispersion are again described in EP-B 0 605 497 or EP-B 0 167 825.
  • the average particle diameter in the solid ester polyol phase is preferably 40 to 1000 nm.
  • the oil phase can contain the additives customary for SPN dispersion, such as gel formers, cross-polymers, cellulose derivatives, xanthan gum, gelatin or pectins. Other ingredients are known to the person skilled in the art.
  • the emulsions or dispersions according to the invention are preferably used in cosmetic and / or pharmaceutical and / or active ingredient compositions.
  • the invention thus also relates to such cosmetic and / or pharmaceutical and / or agro-active substance compositions which contain at least one of the emulsions mentioned.
  • the cosmetic and / or pharmaceutical compositions can be hand or body lotions, oils, ointments, pastes, gels, lip care products, face care products and similar compositions.
  • the compositions can be used in solid, liquid or aerosol form.
  • este polyols as solvents, solubilizers or dispersants for slightly soluble ( ⁇ 10% solubility) or insoluble organic compounds in lipophilic and hydrophilic media.
  • Suitable molecules or groups of molecules are, for example, salicylic acid, sphingosines, ceramides, trite ⁇ enic acid such as oleanolic acid, betulinic acid, betulin, ursolic acid, boswellic acid, 18-ß-glycyrrhetic acid, forskolin, sclareolide, andrographolides.
  • total extracts from plants that include contain the above molecules or classes of molecules.
  • oils mentioned above can be considered as lipophilic media and aqueous media with a water content of at least 80, preferably at least 90, in particular at least 95% by weight as hydrophilic media.
  • Compounds whose solubility is below 3%, preferably below 1%, in particular below 0.5%, are regarded as insoluble.
  • the invention also relates to a solution of organic compounds insoluble in lipophilic and hydrophilic media in este polyols, which are structured as defined above.
  • the invention further relates to the use of este polyols as solubilizers for introducing cosmetic and / or pharmaceutical and / or agroactive ingredients into polyol-in-oil emulsions or polyol-in-oil-in-water emulsions or corresponding dispersions.
  • the emulsions or dispersions according to the invention can have a transport and a depot effect for the active substances contained therein. They can not only act as carriers but also as depots, which allow a delayed release of the active ingredient over a certain period of time.
  • Active substances which are sensitive to oxidation and sensitive to hydrolysis can be encapsulated in a stable manner and in particular in a stable manner over a longer period of time.
  • the emulsions and dispersions according to the invention can reliably prevent moisture attack on the active ingredients.
  • Active ingredients which are insoluble in hydrophilic and lipophilic media can be administered in the form of an emulsion or dispersion.
  • the penetration properties of the cosmetic or pharmaceutical compositions can be positively influenced by using the emulsions according to the invention.
  • a depot effect and improved penetration can be achieved in particular in the multiple emulsions described.
  • the skin permeability barrier is overcome in that by forming liquid-crystalline gel network structures in the multiple emulsions described, an order is established which corresponds to that of the lipid barrier of the skin.
  • the penetration properties of the pharmacological and cosmetic active ingredients mentioned are decisively improved. The same applies to the dispersions.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

The invention relates to ester polyols which are derived from glycerine, C2-20-alkylene glycol, poly(C2-20-alkylene)glycol, ethylene glycol, polyethylene glycol, preferably in which up to 30 % of the ethyleneoxy units can be replaced by propyleneoxy units, polyglycerines, sorbitol and pentaerythritol, as polyol constituents, and aliphatic C3-6-carboxylic acids, as acid constituents, which, in addition to a carboxyl group, comprise at least one other functional group selected from hydroxyl and carboxyl groups; or mixtures of the ester polyols with aminofunctional polyols having a melting point lower than 100 °C; or ester polyols of general formula (I): R1-O-[EO-]n[PO-]mR2 wherein R1 represents C1-4-alkyl, R2 represents hydrogen or C1-4-alkyl, n represents on average between 1 and 100, m represents on average between 0 and n/2, and EO and PO represent base units which are derived from ethylene oxide and propylene oxide and can be in any sequence when both base units are present. According to the invention, said ester polyols can be used as solvents, solubilisers, or dispersants for organic compounds which are insufficiently soluble or insoluble in lipophile and hydrophile media, for pharmaceutical, cosmetic, washing agent, food, or agrarian active ingredients, and as dispersants or continuous phases for (micro)pigment dispersions.

Description

Esterpolyole als Lösungsmittel und diese enthaltende Emulsionen und DispersionenEster polyols as solvents and emulsions and dispersions containing them
Die Erfindung betrifft die Veπvendung von Esteφolyolen als Lösungsmittel oder Lösungsvermittler für in lipophilen und hydrophilen Medien unzureichend lösliche oder unlösliche organische Verbindungen sowie als Dispergiermittel für (Micro)Pigmente. Die Erfindung betrifft ferner Esteφolyole enthaltende Esteφolyol/Polyol-in-Öl-Emulsionen (EP/O-Emulsionen), Verfahren zu ihrer Herstellung, diese Emulsionen enthaltende Esterpolyol/Polyol-in-Öl-in- Wasser-Emulsionen (EP/O/W-Emulsionen), derenThe invention relates to the use of este polyols as solvents or solubilizers for organic compounds which are insufficiently soluble or insoluble in lipophilic and hydrophilic media and as dispersants for (micro) pigments. The invention further relates to este polyol / polyol-in-oil emulsions (EP / O emulsions) containing este polyols, processes for their preparation, ester polyol / polyol-in oil in water emulsions (EP / O / W) containing these emulsions Emulsions), their
Verwendung in kosmetischen und/oder pharmazeutischen und/oder waschmitteltechnologischen und/oder lebensmitteltechnologischen und/oder agrartechnologischen Wirkstoff-Zusammensetzungen und derartige Zusammensetzungen.Use in cosmetic and / or pharmaceutical and / or detergent technology and / or food technology and / or agricultural technology active ingredient compositions and compositions of this type.
In kosmetischen und/oder pharmazeutischen und/oder Agrowirkstoff-Zusammensetzungen werden häufig Emulsionen mit Wirkstoffen eingesetzt, mit denen für die gewünschte Anwendungsform geeignete Zusammensetzungen hergestellt werden können. Die Herstellung von Polyol-in-Öl-Emulsionen und Polyol-in-Öl-in- Wasser-Emulsionen ist an sich bekannt. Mit Hilfe derartiger Emulsionen können kosmetische und/oder pharmazeutische Wirkstoffe in eine für die Anwendung geeignete Form überführt werden. Die DE-A-43 41 114 betrifft wasserfreie X/O-Emulsionen, die eine nichtwässrige, mit Öl nicht mischbare Phase und eine Ölphase enthalten. 1h der nichtwässrigen, mit Öl nicht mischbaren Phase kann ein Wirkstoff, der auch als Feststoff vorliegen kann, für beispielsweise medizinische, kosmetische oder technische Anwendungen enthalten sein. Die Emulsion wird unter Verwendung eines speziellen Emulgators hergestellt, der einen HLB-Wert von maximal 6 hat oder ein W/O-Emulgator ist. Als einsetzbares Polyol werden Propylenglykol, Butylenglykol, Polyalkylenglykol, Glycerin, Polyglycerin und deren Mischungen erwähnt.In cosmetic and / or pharmaceutical and / or agro-active ingredient compositions, emulsions with active ingredients are often used, with which suitable compositions can be produced for the desired form of use. The production of polyol-in-oil emulsions and polyol-in-oil-in-water emulsions is known per se. Such emulsions can be used to convert cosmetic and / or pharmaceutical active ingredients into a form suitable for use. DE-A-43 41 114 relates to anhydrous X / O emulsions which contain a non-aqueous, oil-immiscible phase and an oil phase. 1 h of the non-aqueous, oil-immiscible phase, an active ingredient, which can also be in the form of a solid, can be present for medical, cosmetic or technical applications, for example. The emulsion is made using a special emulsifier that has a maximum HLB of 6 or is a W / O emulsifier. Propylene glycol, butylene glycol, polyalkylene glycol, glycerin, polyglycerol and mixtures thereof are mentioned as usable polyol.
Die DE-A-43 41 113 betrifft eine stabile multiple Emulsion vom X/O/Y-Typ. Dabei ist X eine mit Öl nicht mischbare Komponente, O eine Ölphase und Y eine wässrige Phase. Es werden insbesondere W/O/W-Emulsionen und P/O/W-Emulsionen beschrieben, wobei als Polyolphase wiederum Propylenglykol, Butylenglykol, Polyalkylenglykol, Glycerin, Polyglycerin oder deren Mischungen eingesetzt werden können.DE-A-43 41 113 relates to a stable multiple emulsion of the X / O / Y type. X is an oil-immiscible component, O an oil phase and Y an aqueous phase. W / O / W emulsions and P / O / W emulsions are described in particular, it being possible in turn to use propylene glycol, butylene glycol, polyalkylene glycol, glycerin, polyglycerol or mixtures thereof as the polyol phase.
Zahlreiche kosmetische oder pharmazeutische oder Agrowirkstoffe sind nicht in hydrophilen und lipophilen Medien löslich. Sie sind insbesondere nicht in Wasser oder Öl löslich. Derartige Wirkstoffe können daher häufig nur in Form feinteiliger Dispersionen der Feststoffe in Trägermedien appliziert werden, was zu Nachteilen bei der Formulierung, Dosierung und Anwendung führt. Durch das Vorliegen von Feststoffen werden komplexe Formulierungen der kosmetischen oder pharmazeutischen Zusammensetzungen erhalten. Zudem können Wirkstoffe häufig nicht in geeigneter Form einer Anwendung zugeführt werden.Many cosmetic or pharmaceutical or agro active ingredients are not soluble in hydrophilic and lipophilic media. In particular, they are not soluble in water or oil. Such active substances can therefore often only be applied in the form of finely divided dispersions of the solids in carrier media, which leads to disadvantages in terms of formulation, dosage and use. The presence of solids results in complex formulations of the cosmetic or pharmaceutical compositions. In addition, active ingredients can often not be used in a suitable form for an application.
Aufgabe der vorliegenden Erfindung ist die Bereitstellung von kosmetisch, pharmazeutisch und agrotechnisch verträglichen Lösungsvermittlern für in hydrophilen und lipophilen Medien unzureichend lösliche oder unlösliche Wirkstoffe. Weiterhin sollen Polyol-in-Öl-Emulsionen mit einer neuartigen Polyolersatzkomponente bereitgestellt werden, wobei die Ersatzkomponente als Lösungsvermittler für die Wirkstoffe wirken kann. Den Nachteilen der bekannten Wirkstofformulierungen soll damit abgeholfen werden. Ferner sollen alternative Solid Lipid Nanoparticle- (SLN)Systeme zur Verfügung gestellt werden..The object of the present invention is to provide cosmetically, pharmaceutically and agrotechnologically compatible solubilizers for active ingredients which are insufficiently soluble or insoluble in hydrophilic and lipophilic media. Furthermore, polyol-in-oil emulsions are to be provided with a novel polyol substitute component, the substitute component being able to act as a solubilizer for the active ingredients. The aim is to remedy the disadvantages of the known active substance formulations. Alternative solid lipid nanoparticle (SLN) systems are also to be made available.
Die Aufgabe wird erfindungsgemäß gelöst durch die Verwendung von Esterpolyolen, die sich vonThe object is achieved by the use of ester polyols, which differ from
Glycerin, C2-20-Alkylenglycol, vorzugsweise C -10-Alkylenglykol, insbesondere C2-8- Alkylenglykol, zum Beispiel Propylenglykol, Butylenglykol und speziell Ethylenglykol, Poly(C2-20-alkylen)glykol, vorzugsweise Poly(C2-10-alkylen)glykol, insbesondere Poly(C2- 8-alkylen)glykol, mit einem oder mehreren unterschiedlichen Alkylenresten, zum Beispiel Polyethylenglykol, in dem bis zu 30% der Ethylenoxyeinheiten durch Propylenoxyeinheiten ersetzt sein können, Polyglycerinen, Sorbitol, Pentaerythritol als Polyolkomponente undGlycerol, C 2-20 alkylene glycol, preferably C -10 alkylene glycol, especially C 2-8 alkylene glycol, for example propylene glycol, butylene glycol and especially ethylene glycol, poly (C 2-20 alkylene) glycol, preferably poly (C 2- 10- alkylene) glycol, in particular poly (C 2- 8 alkylene) glycol, with one or more different alkylene radicals, for example polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, polyglycerols, sorbitol, pentaerythritol as the polyol component and
aliphatischen C3-6-Carbonsäuren, die neben einer Carboxylgruppe mindestens eine weitere funktionelle Gruppe, ausgewählt aus Hydroxyl- und Carboxylgruppen, aufweisen, als S äurekomponentealiphatic C 3-6 carboxylic acids which, in addition to a carboxyl group, have at least one further functional group selected from hydroxyl and carboxyl groups, as the acid component
ableiten, oder Gemischen der Esteφolyole mit ∑uriinofunktionellen Polyolen mit einem Schmelzpunkt von weniger als 100°C oder Esteφolyolen der allgemeinen Formel (I) R'-O-IΈO- PO- R2 derive, or mixtures of the este polyols with uri-functional polyols with a melting point of less than 100 ° C or este polyols of the general formula (I) R'-O-IΈO-PO- R 2
(I)(I)
mit der Bedeutungwith the meaning
R1-4-Alkyl,R 1 -C -4 alkyl,
R Wasserstoff oder C1-4-Alkyl, n im Mittel 1 bis 100, m im Mittel 0 bis n/2R is hydrogen or C 1-4 alkyl, n on average 1 to 100, m on average 0 to n / 2
EO, PO von Ethylenoxid und Propylenoxid abgeleitete Grundbausteine, die beim Vorliegen beider Grundbausteine in beliebiger Reihenfolge vorliegen können,EO, PO basic building blocks derived from ethylene oxide and propylene oxide, which can exist in any order if both basic building blocks are present,
als Lösungsmittel, Lösungsvermittler oder Dispergierhilfsmittel für in lipophilen und hydrophilen Medien unzureichend lösliche oder unlösliche organische Verbindungen, pharmazeutische, kosmetische, waschmitteltechnologische, lebensmittel-technologische oder agrartechnologische Wirkstoffe und als Dispergierhilfsmittel oder kontinuierliche Phase für (Micro)pigment-Dispersionen.as a solvent, solubilizer or dispersion aid for organic compounds which are insufficiently soluble or insoluble in lipophilic and hydrophilic media, pharmaceutical, cosmetic, detergent technology, food technology or agricultural technology active ingredients and as a dispersion aid or continuous phase for (micro) pigment dispersions.
Die Esteφolyole, die erfindungsgemäß eingesetzt werden, leiten sich von Polyolkomponenten und Säurekomponenten ab, die miteinander verestert sind. Als Polyolkomponente kommen Glycerin, Ethylenglykol, Polyethylenglykol, in dem bis zu 30% der Ethylenoxyeinheiten durch Propylenoxyeinheiten ersetzt sein können, und deren Gemische zum Einsatz. Im Polyethylenglykol liegen vorzugsweise 1 bis 600, besonders bevorzugt 1 bis 100 Ethylenoxyeinheiten vor.The este polyols which are used according to the invention are derived from polyol components and acid components which are esterified with one another. Glycerol, ethylene glycol, polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, and mixtures thereof are used as the polyol component. The polyethylene glycol preferably contains 1 to 600, particularly preferably 1 to 100, ethyleneoxy units.
Als Säurekomponente kommen aliphatische C3-6-Carbonsäuren zum Einsatz, die neben einer Carboxylgruppe mindestens eine weitere funktionelle Gruppe, ausgewählt aus Hydroxyl- und Carboxylgruppen, aufweisen. Vorzugsweise enthalten die Carbonsäuren nur Kohlenstoff, Wasserstoff und Sauerstoff als Atome. Die Kohlenstoffkette kann dabei frei von Doppelbindungen sein oder eine Doppelbindung enthalten. Beispiele geeigneter Säurekomponenten sind Milchsäure, Maleinsäure, Weinsäure und Citronensäure.Aliphatic C 3-6 carboxylic acids are used as the acid component which, in addition to a carboxyl group, have at least one further functional group selected from hydroxyl and carboxyl groups. The carboxylic acids preferably contain only carbon, hydrogen and oxygen as atoms. The carbon chain can be free of double bonds or contain a double bond. Examples of suitable acid components are lactic acid, maleic acid, tartaric acid and citric acid.
In den Esteφolyolen können eine, zwei, drei oder mehr, beispielsweise alle Hydroxylgruppen der Polyolkomponente verestert vorliegen. Ebenso können eine, zwei, mehrere oder alle Carboxylgruppen der Säurekomponente in Esterform vorliegen. Die erfindungsgemäß eingesetzten Esteφolyole können bei Raumtemperatur (25°C) in fester, glasähnlicher, zähflüssiger oder flüssiger Form vorliegen. Durch Mischung mehrerer Esteφolyole können die Eigenschaften gezielt eingestellt werden. Beispielsweise liegen Lactate in der Regel flüssig vor, während Citrate in einem glasähnlichen Zustand vorliegen und erst bei einer Temperatur von etwa 50°C zähflüssig werden. Ein Gemisch aus Citrat und Lactat im Verhältnis 1 :1 ist glasähnlich. Ein Gemisch von Citrat und Lactat im Gewichtsverhältnis 1 :2 ist demgegenüber zähflüssig. Häufig sind die Esteφolyole bei Raumtemperatur glasklar und fest.One, two, three or more, for example all, hydroxyl groups of the polyol component may be esterified in the este polyols. Likewise, one, two, more or all of the carboxyl groups of the acid component can be in ester form. The este polyols used according to the invention can be in solid, glass-like, viscous or liquid form at room temperature (25 ° C.). The properties can be specifically adjusted by mixing several este polyols. For example, lactates are usually in liquid form, while citrates are in a glass-like state and only become viscous at a temperature of around 50 ° C. A 1: 1 mixture of citrate and lactate is similar to glass. In contrast, a mixture of citrate and lactate in a weight ratio of 1: 2 is viscous. The este polyols are often crystal clear and solid at room temperature.
Die Esteφolyole können in Kombination mit aminofunktionellen Polyolen, Etheralkoholen oder beiden Verbindungen eingesetzt werden. Der Anteil der Esteφolyole an derartigen Gemischen beträgt vorzugsweise mindestens 10 Gew.-%, besonders bevorzugt mindestens 15 Gew.-%, insbesondere mindestens 20 Gew.-%.The este polyols can be used in combination with amino-functional polyols, ether alcohols or both compounds. The proportion of este polyols in such mixtures is preferably at least 10% by weight, particularly preferably at least 15% by weight, in particular at least 20% by weight.
Als aminofunktionelles Polyol kann jedes geeignete aminofunktionelle Polyol eingesetzt werden, das einen Schmelzpunkt von weniger als 100 °C, vorzugsweise von weniger als 50 °C aufweist. Der Ausdruck ''aminofunktionelle'' Polyole bedeutet, dass im Polyol mindestens eine Amingruppe oder Amidgrappe vorliegt. Das Polyol weist zudem mindestens zwei Hydroxylgruppen auf. Es kann sich dabei um ein aliphatisches, aromatisches oder aromatisch/aliphatisches Polyol handeln. Vorzugsweise handelt es sich um ein aliphatisches Polyol. Besonders bevorzugt liegen im Polyol 2 bis 10, besonders bevorzugt 2 bis 5, insbesondere 2 bis 3 Hydroxylgruppen vor. Die aminofunktionellen Polyole können über die genannten funktionellen Gruppen hinaus Carbonylgruppen, Carboxylgruppen, Thiolgruppen und Kohlenstoff-Kohlenstoff-Doppelbindungen oder - Dreifachbindungen aufweisen. Sie können zudem Ethergruppen aufweisen. Ein Teil der im Molekül vorliegenden Hydroxylgruppen kann derart verethert sein, unter der Voraussetzung, dass mindestens zwei freie Hydroxylgruppen im Molekül vorliegen. Vorzugsweise enthalten die erfindungsgemäß eingesetzten aminofunktionellen Polyole eine oder zwei Amidgruppen.Any suitable amino-functional polyol which has a melting point of less than 100 ° C., preferably less than 50 ° C., can be used as the amino-functional polyol. The term "amino-functional" polyols means that there is at least one amine group or amide group in the polyol. The polyol also has at least two hydroxyl groups. It can be an aliphatic, aromatic or aromatic / aliphatic polyol. It is preferably an aliphatic polyol. The polyol particularly preferably contains 2 to 10, particularly preferably 2 to 5, in particular 2 to 3, hydroxyl groups. In addition to the functional groups mentioned, the amino-functional polyols can have carbonyl groups, carboxyl groups, thiol groups and carbon-carbon double bonds or triple bonds. They can also have ether groups. Some of the hydroxyl groups present in the molecule can be etherified, provided that at least two free hydroxyl groups are present in the molecule. The amino-functional polyols used according to the invention preferably contain one or two amide groups.
Bevorzugt werden erfindungsgemäß aminofunktionelle Polyole eingesetzt, die zwei oder drei Hydroxylgruppen und eine oder zwei Amidgruppen aufweisen. Sie können ferner eine zusätzliche Thiolgruppe oder Carboxylgruppe aufweisen. Vorzugweise enthalten die Verbindungen 5 bis 15 Kohlenstoffatome, besonders bevorzugt 7 bis 12 Kohlenstoffatome.According to the invention, it is preferred to use amino-functional polyols which have two or three hydroxyl groups and one or two amide groups. They can also have an additional thiol group or carboxyl group. The compounds preferably contain 5 to 15 carbon atoms, particularly preferably 7 to 12 carbon atoms.
Vorzugsweise ist das aminofunktionelle Polyol ein Pantothenderivat der allgemeinen Formel (II) HO-CH2-C(CH3)2-CH(OH)-CO-NH-CH2-CH2-RThe amino-functional polyol is preferably a pantothene derivative of the general formula (II) HO-CH 2 -C (CH 3 ) 2 -CH (OH) -CO-NH-CH 2 -CH 2 -R
(II)(II)
mit R COOK1, CH OR1, CO-NH-CH2-CH2-SR1 with R COOK 1 , CH OR 1 , CO-NH-CH2-CH 2 -SR 1
R1 H, Ci.u-Al yl, Phenyl.R 1 H, Ci.u-Al yl, phenyl.
Vorzugsweise ist R ein Rest CH2-OR1. Vorzugsweise ist R1 Wasserstoff oder C1-6-Alkyl, insbesondere Wasserstoff oder C1-3-Alkyl.R is preferably a CH 2 -OR 1 radical. R 1 is preferably hydrogen or C 1-6 alkyl, in particular hydrogen or C 1-3 alkyl.
Besonders bevorzugt werden Pantothensäure, Panthenol oder Panthetein eingesetzt. Die Pantothenderivate liegen vorzugsweise in der (R)-Form vor. Pantothensäure kann auch in Form der Salze eingesetzt werden, speziell bevorzugt ist das Pantothenderivat (R)- Panthenol.Pantothenic acid, panthenol or panthetein are particularly preferably used. The pantothene derivatives are preferably in the (R) form. Pantothenic acid can also be used in the form of the salts, the pantothen derivative (R) - panthenol being particularly preferred.
Die erfindungsgemäß bevorzugt eingesetzten Verbindungen weisen einen Molekülabschnitt auf, der sich von Pantoinsäure ableitet, sowie einen Molekülabschnitt, der sich von ß -Alanin ableitet, sofern es sich um eine Pantothensäure- ergleichbare Verbindung handelt.The compounds preferably used according to the invention have a molecular segment which is derived from pantoic acid, and a molecular segment which is derived from β-alanine, provided that it is a compound comparable to pantothenic acid.
Panthenol und Pantothensäure sind aus dem medizinischen Bereich zur Wundheilung sowie aus Haarbehandlungsmitteln und Futterzusätzen bekannt. Die Herstellung kann über eine Biosynthese aus 2-Oxo-3-methylbutansäure oder aus Pantolacton erfolgen. Weitere Herstellungsverfahren sind allgemein bekannt. Es kann femer auf Beilstein EIV 4, 2571, Beilstein EV 18/1, 22 und Beilstein E IV 4, 2569f sowie Isler et al., Vitamine II, Seiten 309 bis 339, Thieme-Verlag, Stuttgart, 1988 verwiesen werden. Es gibt zudem eine umfängliche Patentliteratur, die sich mit dem Einsatz von Pantothenderivaten, insbesondere von Panthenol in kosmetischen und pharmazeutischen Zusammensetzungen befaßt.Panthenol and pantothenic acid are known from the medical field for wound healing as well as from hair treatment agents and feed additives. The preparation can be carried out via biosynthesis from 2-oxo-3-methylbutanoic acid or from pantolactone. Other manufacturing processes are generally known. Reference can also be made to Beilstein EIV 4, 2571, Beilstein EV 18/1, 22 and Beilstein E IV 4, 2569f and Isler et al., Vitamine II, pages 309 to 339, Thieme-Verlag, Stuttgart, 1988. There is also extensive patent literature dealing with the use of pantothen derivatives, in particular panthenol, in cosmetic and pharmaceutical compositions.
In den Esteφolyolen der allgemeinen Formel (I) können von Ethylenoxid und gegebenenfalls zusätzlich von Propylenoxid abgeleitete Grundbausteine vorliegen. Diese Grundbausteine haben die Strukturen -CH2-CH2-O-, -CH2-CH(CH3)-O- und -CH(CH3)- CH2-O-. Wenn die beiden von Ethylenoxid und Propylenoxid abgeleiteten Grundbausteine vorliegen, können sie in beliebiger Reihenfolge vorliegen. Dies bedeutet, daß jeweils ein oder mehrere von Ethylenoxid und Propylenoxid abgeleitete Blöcke miteinander verbunden sein können. Femer können die von Ethylenoxid und Propylenoxid abgeleiteten Einheiten auch alternierend oder statistisch vorliegen. Die zwischen diesen Formen möglichen kontinuierlichen Übergänge sind ebenfalls erfindungsgemäß möglich. In der allgemeinen Formel (I) ist der Anteil der von Propylenoxid abgeleiteten Grundbausteine maximal ein Bruchteil der Menge von Ethylenoxid abgeleiteten Grundbausteine.. Während im Mittel 1 bis 100, vorzugsweise 2 bis 70, besonders bevorzugt 3 bis 50, insbesondere 5 bis 15 von Ethylenoxid abgeleitete Grundbausteine vorliegen, liegen 0 bis n 2, vorzugsweise 0 bis n/4, besonders bevorzugt 0 bis n/8 von Propylenoxid abgeleitete Grundbausteine im Mittel vor. Sofern von Propylenoxid abgeleitete Grundbausteine vorliegen, beträgt ihre Menge vorzugsweise n/10 bis n/4, besonders bevorzugt n/8 bis n/5. Bei den Zahlen n und m handelt es sich um Mittelwerte, da sich bei der Alkoxylierang in der Regel eine Verteilung des Alkoxylierungsgrades einstellt. Deshalb sind auch ungradzahlige Werte für n und m möglich. Die Breite der Verteilung des Alkoxylierungsgrades hängt unter anderem auch vom verwendeten Alkoxylierungskatalysator ab. Es ist auch möglich, diskrete Alkoxylierungsgrade oder sehr eng verteilte Verteilungen des Alkoxylierungsgrades einzustellen.Basic building blocks derived from ethylene oxide and optionally additionally from propylene oxide can be present in the este polyols of the general formula (I). These basic building blocks have the structures -CH 2 -CH 2 -O-, -CH 2 -CH (CH 3 ) -O- and -CH (CH 3 ) - CH 2 -O-. If the two basic building blocks derived from ethylene oxide and propylene oxide are present, they can be in any order. This means that one or more blocks derived from ethylene oxide and propylene oxide can be connected to one another. The units derived from ethylene oxide and propylene oxide can also be present alternately or statistically. The continuous transitions possible between these forms are also possible according to the invention. In the general formula (I), the proportion of the basic building blocks derived from propylene oxide is at most a fraction of the amount of basic building blocks derived from ethylene oxide. While on average 1 to 100, preferably 2 to 70, particularly preferably 3 to 50, in particular 5 to 15, of ethylene oxide derived basic building blocks are present, there are 0 to n 2, preferably 0 to n / 4, particularly preferably 0 to n / 8 basic building blocks derived from propylene oxide. If basic building blocks derived from propylene oxide are present, their amount is preferably n / 10 to n / 4, particularly preferably n / 8 to n / 5. The numbers n and m are average values, since the alkoxylation range generally results in a distribution of the degree of alkoxylation. Therefore, odd-numbered values for n and m are also possible. The breadth of the distribution of the degree of alkoxylation also depends, inter alia, on the alkoxylation catalyst used. It is also possible to set discrete degrees of alkoxylation or very narrow distributions of the degree of alkoxylation.
R1 ist ein C1-4-Alkylrest, vorzugsweise C1-3-Alkylrest, besonders bevorzugt C1- -Alkylrest, insbesondere ein Methylrest. Propylreste umfassen n-Propyl und iso-Propyl, während Butylreste n-Butyl, iso-Butyl, tertButyl umfassen.R 1 is a C 1-4 alkyl radical, preferably C 1-3 alkyl radical, particularly preferably C 1- alkyl radical, in particular a methyl radical. Propyl residues include n-propyl and iso-propyl, while butyl residues include n-butyl, iso-butyl, tert-butyl.
11
R bedeutet Wasserstoff oder einen Rest, wie er vorstehend für R definiert ist. Dabei ist die Bedeutung von R2 unabhängig von der Bedeutung des Restes R1. Besonders bevorzugt ist R2 Wasserstoff. Der in der Beschreibung und den Ansprüchen verwendete Ausdruck "Esteφolyol" umfaßt sämtliche Verbindungen der allgemeinen Formel (I), d.h. auch die Fälle, in denen R2 kein Wasserstoffatom ist und somit keine freien Hydroxylgruppen im Molekül vorliegen.R represents hydrogen or a radical as defined for R above. The meaning of R 2 is independent of the meaning of the radical R 1 . R 2 is particularly preferably hydrogen. The term "Estolyol" used in the description and the claims includes all compounds of the general formula (I), ie also the cases in which R 2 is not a hydrogen atom and thus there are no free hydroxyl groups in the molecule.
Bevorzugt handelt es sich beim Esteφolyol um ein Methanolethoxylat mit 5 bis 15 Ethylenoxid-Einheiten.The este polyol is preferably a methanol ethoxylate with 5 to 15 ethylene oxide units.
Speziell bevorzugt werden Polyethylenglykolmonomethylether (12EO) und Polyethylenglykolmonomethylether (7EO) eingesetzt. Hierbei handelt es sich um reine Methylalkoholethoxylate. Derartige Verbindungen sind an sich bekannt und wurden bisher für die Herstellung von methylendgruppenverschlossenenPolyethylene glycol monomethyl ether (12EO) and polyethylene glycol monomethyl ether (7EO) are particularly preferably used. These are pure methyl alcohol ethoxylates. Such compounds are known per se and have hitherto been used for the preparation of methyl end groups
Fettsäurepolyethylenglykolestern eingesetzt. Die Verbindungen sind handelsüblich.Fatty acid polyethylene glycol esters used. The connections are commercially available.
Erfindungsgemäß werden besonders bevorzugt Esteφolyole der allgemeinen Formel (I) eingesetzt, die bei Raumtemperatur (25°C) flüssig sind. Der Ausdruck "Esteφolyol/Polyol", wie er zur Beschreibung von Esteφθlyol/Polyol-in- Öl-Emulsionen (EP/O), Esteφolyol/Polyol-Phasen und Esteφolyol/Polyol-in-Öl-in- Wasser-Emulsionen (EP/O/W) verwendet wird, gibt an, daß eine Esteφolyolphase oder eine gemischte Esteφolyol/Polyol-Phase vorliegen kann. Die entsprechende Trägeφhase wird damit entweder nur durch die Esteφolyole der allgemeinen Formel (I) gebildet, oder es liegen Gemische der Esteφolyole mit Polyolen, Etheralkoholen, oder aminofunktionellen Polyolen vor. Zusätzlich köm en, wie im folgenden beschrieben, organische oder anorganische Verbindungen in der Esteφolyol/Polyol-Phase vorliegen.According to the invention, particular preference is given to using este polyols of the general formula (I) which are liquid at room temperature (25 ° C.). The expression "Esteφolyol / Polyol" as used to describe Esteφθlyol / Polyol-in-Oil Emulsions (EP / O), Esteφolyol / Polyol phases and Esteφolyol / Polyol-in-Oil-in-Water Emulsions (EP / O / W) is used, indicates that an Esteφolyolphase or a mixed Esteφolyol / Polyol phase can be present. The corresponding carrier phase is thus either formed only by the ester polyols of the general formula (I), or there are mixtures of the ester polyols with polyols, ether alcohols or amino-functional polyols. In addition, as described below, organic or inorganic compounds may be present in the ester polyol / polyol phase.
In den erfindungsgemäßen Esteφolyol/Polyol-in-Öl-Emulsionen (EP/O-Emulsionen) können eine oder mehrere Esteφolyol/Polyolphasen vorliegen. Vorzugsweise liegt eine Esteφolyol/Polyolphase vor, die mindestens ein wie vorstehend beschriebenen Esteφolyol enthält. Vorzugsweise liegen in der Polyolphase mindestens 10 oder mindestens 50 Gew.-%, besonders bevorzugt mindestens 80 Gew.-%, insbesondere mindestens 95 Gew.-% des Esteφolyols vor, bezogen auf die gesamte Esteφolyol/Polyolphase.- In der Esteφolyol/Polyolphase kann auch Wasser in einer Menge von maximal 20 Gew.-%, vorzugsweise maximal 10 Gew.-%, insbesondere maximal 5 Gew.-% enthalten sein, bezogen auf die gesamte Esteφolyol/Polyolphase. Vorzugsweise ist die Esteφolyol/Polyolphase weitgehend oder vollständig wasserfrei. Die Summe aus Esteφolyol, gegebenenfalls Etheralkohol, aminofunktionellem Polyol, anderem Polyol und Wasser ergibt dabei 100 Gew.-%.One or more este polyol / polyol phases can be present in the este polyol / polyol-in-oil emulsions (EP / O emulsions) according to the invention. Preferably there is an este polyol / polyol phase which contains at least one este polyol as described above. At least 10 or at least 50% by weight, particularly preferably at least 80% by weight, in particular at least 95% by weight, of the este polyol are preferably present in the polyol phase, based on the total este polyol / polyol phase. - In the este polyol / polyol phase water may also be present in an amount of at most 20% by weight, preferably at most 10% by weight, in particular at most 5% by weight, based on the total estepolyol / polyol phase. The este polyol / polyol phase is preferably largely or completely anhydrous. The sum of este polyol, optionally ether alcohol, amino-functional polyol, other polyol and water is 100% by weight.
Als Polyole können die üblichen bekannten Polyole wie Propylenglykol, Butylenglykol, Ethylenglykol, Polyalkylenglykol, Glycerin, Polyglycerin, Glycoside, Sorbit, Mannit, Pentaerythrit, Trimethylolpropan oder Mischungen davon vorliegen. Als Polyalkylenglykole kommen insbesondere Polyethylenglykol und Polypropylenglykol in Frage. Weitere geeignete Polyole sind dem Fachmann bekannt, beispielsweise aromatische Polyole wie Emodin/Aloe Vera. Diese Polyole können auch Grundlage der vorstehenden Esteφolyole sein.The customary known polyols such as propylene glycol, butylene glycol, ethylene glycol, polyalkylene glycol, glycerol, polyglycerol, glycosides, sorbitol, mannitol, pentaerythritol, trimethylolpropane or mixtures thereof can be present as polyols. Polyalkylene glycols in particular include polyethylene glycol and polypropylene glycol. Other suitable polyols are known to the person skilled in the art, for example aromatic polyols such as Emodin / Aloe Vera. These polyols can also be the basis of the above este polyols.
Besonders bevorzugt liegen in der Esteφolyol/Polyolphase einzig Esteφolyole vor, wie sie vorstehend beschrieben sind.Particularly preferably, only esteolyols as described above are present in the estepholyol / polyol phase.
Die Esteφolyol/Polyolphase ist erfindungsgemäß nicht mit Öl mischbar. Dies bedeutet, daß sich bei der Herstellung der erfϊndungsgemäßen EP/O-Emulsionen vorzugsweise kein Esteφolyol/Polyol in der Ölphase löst bzw. Öl in der Esteφolyol/Polyolphase löst. Geringfügige Abweichungen hiervon (etwa bis zu 5 Gew.-%, vorzugsweise bis zu etwa 1 Gew.-%, insbesondere bis zu etwa 0,5 Gew.-% Löslichkeit) sind hierbei unbeachtlich. Es kommt darauf an, dass in der EP/O-Emulsion eine Emulsion der Esteφolyol/Polyolphase in der Ölphase erhalten wird und keine Lösung des Esteφolyol/Polyols im Öl.According to the invention, the este polyol / polyol phase is not miscible with oil. This means that when the EP / O emulsions according to the invention are produced, preferably no estepolyol / polyol dissolves in the oil phase or oil dissolves in the estepolyol / polyol phase. Minor deviations from this (about up to 5% by weight, preferably up to about 1% by weight, in particular up to about 0.5% by weight of solubility) are irrelevant here. It depends on the fact that in the EP / O emulsion an emulsion of the este polyol / polyol phase is obtained in the oil phase and not a solution of the este polyol / polyol in the oil.
Als Öl können in der Ölphase alle bekannten geeigneten Öle und deren Gemische eingesetzt werden. Beispiele geeigneter Öle sind Silikonöle und Derivate davon, die linear oder zyklisch sein können, natürliche Esteröle wie Traubenkemöl, Olivenöl oder Sonnenblumenöl, synthetische Esteröle wie Neutralöle, die linear oder verzweigt sein können, Paraffinöle und Isoparaffinöle, Esteröle, beispielsweise der Citrate, Lactate, Aleate, Salicylate, Cinnamate oder andere organische Lichtschutzfilter, oder von Campferderivaten, Triglyceride, Fettalkohole oder Mischungen davon.All known suitable oils and their mixtures can be used as oil in the oil phase. Examples of suitable oils are silicone oils and derivatives thereof, which can be linear or cyclic, natural ester oils such as grape seed oil, olive oil or sunflower oil, synthetic ester oils such as neutral oils, which can be linear or branched, paraffin oils and isoparaffin oils, ester oils, for example the citrates, lactates, aleates , Salicylates, cinnamates or other organic light protection filters, or of camphor derivatives, triglycerides, fatty alcohols or mixtures thereof.
In den EP/O-Emulsionen beträgt das Gewichtsverhältnis von Esteφolyol/Polyolphase zu Ölphase vorzugsweise 10:90 bis 90:10, besonders bevorzugt 25:75 bis 75:25 und insbesondere 40:60 bis 60:40.In the EP / O emulsions, the weight ratio of estepolyol / polyol phase to oil phase is preferably 10:90 to 90:10, particularly preferably 25:75 to 75:25 and in particular 40:60 to 60:40.
Als Emulgatoren können beliebige geeignete Emulgatoren eingesetzt werden, die zur Herstellung einer Emulsion der Esteφolyol/Polyole in Öl geeignet sind. Beispiele geeigneter Emulgatoren sind Glycerinester, Polyglycerinester, Sorbitanester, Sorbitolester, Fettalkohole, Propylenglykolester, Alkylglucositester, Zuckerester, Lecithin, Silikoncopolymere, Wollwachs und deren Mischungen oder Derivate. Glycerinester, Polyglycerinester, Alkoxylate und Fettalkohole sowie Isoalkohole können sich beispielsweise ableiten von Rizinusfettsäure, 12-Hydroxystearinsäure, Isostearinsäure, Ölsäure, Linolsäure, Linolensäure, Stearinsäure, Myristinsäure, Laurinsäure und Caprinsäure. Neben den genannten Estern können auch Succinate, Amide oder Ethanolamide der Fettsäuren vorliegen. Als Fettsäurealkoxylate kommen insbesondere die Ethoxylate, Propoxylate oder gemischten Ethoxylate/Propoxylate in Betracht.Any suitable emulsifiers which are suitable for producing an emulsion of the este polyol / polyols in oil can be used as emulsifiers. Examples of suitable emulsifiers are glycerol esters, polyglycerol esters, sorbitan esters, sorbitol esters, fatty alcohols, propylene glycol esters, alkyl glucose esters, sugar esters, lecithin, silicone copolymers, wool wax and mixtures or derivatives thereof. Glycerol esters, polyglycerol esters, alkoxylates and fatty alcohols and iso alcohols can be derived, for example, from castor fatty acid, 12-hydroxystearic acid, isostearic acid, oleic acid, linoleic acid, linolenic acid, stearic acid, myristic acid, lauric acid and capric acid. In addition to the esters mentioned, succinates, amides or ethanolamides of the fatty acids can also be present. Suitable fatty acid alkoxylates are, in particular, the ethoxylates, propoxylates or mixed ethoxylates / propoxylates.
Die Menge des Emulgators kann den praktischen Erfordernissen angepaßt werden. Vorzugsweise wird der Emulgator in einer Menge von 0,1 bis 20 Gew.-%, besonders bevorzugt 0,5 bis 15 Gew.-%, insbesondere 1 bis 8 Gew.-%, bezogen auf die gesamte EP/O-Emulsion, eingesetzt. Fallweise können hiervon abweichende Dosierungen erforderlich sein.The amount of emulsifier can be adapted to practical requirements. The emulsifier is preferably used in an amount of 0.1 to 20% by weight, particularly preferably 0.5 to 15% by weight, in particular 1 to 8% by weight, based on the entire EP / O emulsion , In some cases, different doses may be necessary.
Gemäß einer Ausfuhrungsform der Erfindung kann die Esteφolyol/Polyolphase bzw. die Esteφolyol-Lösung oder -Dispersion einen in der Phase gelösten kosmetischen und/oder pharmazeutischen Wirkstoff oder Parfüms, Parfumöle oder Aromen enthalten. Es kann sich auch um einen waschmitteltechnologischen, lebensmitteltechnologischen oder agrartechnologischen (Agro-) Wirkstoff handeln. Bei den Wirkstoffen handelt es sich vorzugsweise um in lipophilen und hydrophilen Medien unzureichend lösliche, insbesondere unlösliche organische Verbindungen. Die Verbindungen sind dabei insbesondere in Wasser und Öl unzureichend löslich bzw. unlöslich. Es können beliebige geeignete Wirkstoffe eingesetzt werden, sofern sie sich in dem Esteφolyol bzw. der den Esteφolyol enthaltenden Esteφolyol/Polyolphase lösen. Geeignete Wirkstoffe sind beispielsweise Dichlophenac, Ibuprofen, Acetylsalicylsäure, Salicylsäure, Erythromycin, Ketoprofen, Cortison, Glucocorticoide.According to one embodiment of the invention, the este polyol / polyol phase or the este polyol solution or dispersion can contain a cosmetic and / or pharmaceutical active ingredient or perfume, perfume oils or aromas dissolved in the phase. It can also be a detergent technology, food technology technology or agricultural technology (agro) active ingredient. The active substances are preferably organic compounds which are insufficiently soluble, in particular insoluble, in lipophilic and hydrophilic media. The compounds are insufficiently soluble or insoluble, especially in water and oil. Any suitable active ingredients can be used, provided they dissolve in the este polyol or the este polyol / polyol phase containing the este polyol. Suitable active ingredients are, for example, dichlophenac, ibuprofen, acetylsalicylic acid, salicylic acid, erythromycin, ketoprofen, cortisone, glucocorticoids.
Weiterhin geeignet sind kosmetische Wirkstoffe, die insbesondere oxidations- oder hydrolyseempfindlich sind wie beispielsweise Polyphenole. Hier seien genannt Catechine (wie Epicatechin, Epicatechin-3-gallat, Epigallocatechin, Epigallocatechin-3-gallat), Flavonoide (wie Luteolin, Apigenin, Rutin, Quercitin, Fisetin, Kaempherol, Rhametin), Isoflavone (wie Genistein, Daidzein, Glycitein, Prunetin), Cumarine (wie Daphnetin, Umbelliferon), Emodin, Resveratrol, Oregonin.Also suitable are cosmetic active ingredients that are particularly sensitive to oxidation or hydrolysis, such as polyphenols. Catechins (such as epicatechin, epicatechin-3-gallate, epigallocatechin, epigallocatechin-3-gallate), flavonoids (such as luteolin, apigenin, rutin, quercitin, fisetin, kaempherol, rhametin), isoflavones (such as genistein, glycine, daidzein) Prunetin), coumarins (such as daphnetin, umbelliferon), Emodin, Resveratrol, Oregonin.
Geeignet sind Vitamine wie Retinol, Tocopherol, Ascorbinsäure, Riboflavin, Pyridoxin.Vitamins such as retinol, tocopherol, ascorbic acid, riboflavin, pyridoxine are suitable.
Geeignet sind femer Gesamtextrakte aus Pflanzen, die u.a. obige Moleküle oder Molekülklassen enthalten.Also suitable are total extracts from plants that include contain the above molecules or classes of molecules.
Bei den Wirkstoffen handelt es sich gemäß einer Ausführungsform der Erfindung um Lichtschutzfilter. Diese können als organische Lichtschutzfilter bei Raumtemperatur (25 °C) in flüssiger oder fester Form vorliegen. Geeignete Lichtschutzfilter (UV-Filter) sind beispielsweise Verbindungen auf Basis von Benzophenon, Diphenylcyanacrylat oder p-Aminobenzoesäure. Konkrete Beispiele sind (INCI- oder CTFA-Bezeichnungen) Benzophenone-3, Benzophenone-4, Benzophenone-2, Benzophenone-6, Benzophenone-9, Benzophenone-1, Benzophenone-11, Etocrylene, Octocrylene, PEG-25 PABA, Phenylbenzimidazole Sulfonic Acid, Ethylhexyl Methoxycinnamate, Ethylhexyl Dimethyl PABA, 4-Methylbenzylidene Camphor, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Homosalate sowie Methylene-Bis-Benzotriazolyl Tetramethylbutylphenol (2,2'-Methylen-bis- {6-(2H-benzoetriazol-2-yl)-4-( 1 , 1 ,3 ,3 -tetramethylbutyl)-phenol} , 2- Hydroxy-4-methoxybenzophenon-5-sulfonsäure und 2,4,6-Trianilino-p-(carbo-2'- ethylhexyl- 1 '-oxi)- 1 ,3 ,5-triazin.According to one embodiment of the invention, the active ingredients are light protection filters. These can be in the form of organic light protection filters at room temperature (25 ° C) in liquid or solid form. Suitable light protection filters (UV filters) are, for example, compounds based on benzophenone, diphenyl cyanoacrylate or p-aminobenzoic acid. Specific examples are (INCI or CTFA names) Benzophenone-3, Benzophenone-4, Benzophenone-2, Benzophenone-6, Benzophenone-9, Benzophenone-1, Benzophenone-11, Etocrylene, Octocrylene, PEG-25 PABA, Phenylbenzimidazole Sulfonic Acid, ethylhexyl methoxycinnamate, ethylhexyl dimethyl PABA, 4-methylbenzylidene camphor, butyl methoxydibenzoylmethane, ethylhexyl salicylate, homosalate and methylene-bis-benzotriazolyl tetramethylbutylphenol (2,2'-methylene-bis- {6- (2H-2-benzol) -4- (1, 1, 3, 3 -tetramethylbutyl) phenol}, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and 2,4,6-trianilino-p- (carbo-2'-ethylhexyl-1 ' -oxi) - 1, 3, 5-triazine.
Weitere organische Lichtschutzfilter sind Octyltriazone, Avobenzone, Octylmethoxy- cinnamate, Octylsalicylate, Benzotriazole und Triazine. Die Esteφolyole können auch als Lösungsvermittler und/oder Dispergator für Antischuppenmittel eingesetzt werden.Other organic light protection filters are octyl triazone, avobe zone, octyl methoxy cinnamate, octyl salicylate, benzotriazole and triazine. The este polyols can also be used as solubilizers and / or dispersants for antidandruff agents.
Gemäß einer weiteren Ausführungsform der Erfindung werden als Wirkstoffe Antischuppen-Wirkstoffe eingesetzt, wie sie üblicherweise in kosmetischen oder pharmazeutischen Formulierungen vorliegen. Ein Beispiel hierfür ist Piroctone Olamine (l-Hydroxy-4-methyl-6-(2,4,4-dimethylpentyl)-2(lH)-pyridone; vorzugsweise in Kombination mit 2-Aminoethanol (1:1)). Weitere geeignete Mittel zur Behandlung von Hautschuppen sind dem Fachmann bekannt.According to a further embodiment of the invention, anti-dandruff active ingredients such as are usually present in cosmetic or pharmaceutical formulations are used as active ingredients. An example of this is piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-dimethylpentyl) -2 (1H) -pyridone; preferably in combination with 2-aminoethanol (1: 1)). Other suitable agents for the treatment of skin flakes are known to the person skilled in the art.
Gemäß einer weiteren Ausführungsform der Erfindung werden organische Farbstoffe als Wirkstoffe bzw. an Stelle von Wirkstoffen eingesetzt.According to a further embodiment of the invention, organic dyes are used as active substances or instead of active substances.
Es können beliebige geeignete Mengen des Wirkstoffs in die Esteφolyol/Polyolphase eingebracht werden. Die einbringbare Menge ist häufig durch die Löslichkeit und durch das letztendliche Anwendungsgebiet des Präparats bestimmt. In der Regel werden 0,01 bis 95 Gew.-%, vorzugsweise 0,1 bis 80 Gew.-%, insbesondere 2 bis 50 Gew.-% des Wirkstoffs in das Esteφolyol bzw. die Esteφolyol/Polyolphase eingebracht, wobei sich der Gewichtsanteil auf die Summe von Wirkstoff und Esteφolyol/Polyol bezieht. Anders ausgedrückt kann in der vorstehend angegebenen Menge der Esteφolyol/Polyolphase der angegebene Gewichtsanteil an Esteφolyol/Polyol durch den Wirkstoff ersetzt sein. Beispielsweise können, bezogen auf die reine Esteφolyol/Polyolphase, 0,01 bis 95 Gew.- % der Esteφolyol/Polyolphase durch den Wirkstoff ersetzt werden. Dies bedeutet, daß die vorstehenden Ausführungen zum Anteil der Esteφolyol/Polyolphase an der Emulsion weiterhin zutreffend bleiben. Der Gehalt an Esteφolyol/Polyol bzw. Esteφolyol verringert sich dann gerade um den Anteil an Wirkstoff, der dann in der Esteφolyol/Polyolphase vorliegt.Any suitable amounts of the active ingredient can be introduced into the ester polyol / polyol phase. The amount that can be introduced is often determined by the solubility and the ultimate field of application of the preparation. As a rule, 0.01 to 95% by weight, preferably 0.1 to 80% by weight, in particular 2 to 50% by weight, of the active ingredient are introduced into the estepolyol or the estepolyol / polyol phase, the proportion by weight refers to the sum of active ingredient and este polyol / polyol. In other words, in the amount of estepolyol / polyol phase stated above, the stated proportion by weight of estepolyol / polyol can be replaced by the active ingredient. For example, based on the pure este polyol / polyol phase, 0.01 to 95% by weight of the este polyol / polyol phase can be replaced by the active ingredient. This means that the above statements regarding the proportion of the este polyol / polyol phase in the emulsion remain applicable. The content of Esteφolyol / Polyol or Esteφolyol then just decreases by the proportion of active ingredient which is then present in the Esteφolyol / Polyolphase.
Es ist auch möglich, ein übliches Trägersystem für den Wirkstoff mit dem Esteφolyol aufzufüllen, um zu der genannten Esteφolyol/Polyolphase zu gelangen.It is also possible to fill a conventional carrier system for the active ingredient with the este polyol in order to arrive at the este polyol / polyol phase mentioned.
Die vorstehend beschriebenen EP/O-Emulsion oder -Dispersion kann auch in Wasser oder eine Wasser-in-Öl-Emulsion emulgiert werden. Dabei resultiert eine Esteφolyol/Polyol- in-Öl-in-Wasser-Emulsion (EP/O/W-Emulsion), die mindestens eine wie vorstehend beschriebene Emulsion und zusätzlich mindestens eine wässrige Phase enthält. Derartige multiple Emulsionen können im Aufbau den in DE-A-43 41 113 beschriebenen Emulsionen entsprechen, wobei die Polyolkomponente in erfindungsgemäßer Weise variiert ist. Der Aufbau der Esteφolyol/Polyol-in-Öl-Emulsion kann dem Aufbau der in DE-A-43 41 114 beschriebenen Emulsionen entsprechen, wobei die erfindungsgemäße Esteφolyol/Polyolphase als Polyolphase eingesetzt wird.The EP / O emulsion or dispersion described above can also be emulsified in water or a water-in-oil emulsion. The result is an este polyol / polyol in oil in water emulsion (EP / O / W emulsion) which contains at least one emulsion as described above and additionally at least one aqueous phase. The structure of such multiple emulsions can correspond to the emulsions described in DE-A-43 41 113, the polyol component being varied in the manner according to the invention. The structure of the Esteφolyol / polyol-in-oil emulsion can be the structure of the in DE-A-43 41 114 correspond to the emulsions described, the este polyol / polyol phase according to the invention being used as the polyol phase.
Beim Einbringen der erfindungsgemäßen EP/O-Emulsion in Wasser oder wässrige Systeme kann das Gewichtsverhältnis der einzelnen Phasen in weiten Bereichen variiert werden. Vorzugsweise beträgt in der letztendlich erhaltenen EP/O/W-Emulsion der Gewichtsanteil der EP/O-Emulsion 0,01 bis 80 Gew.-%, besonders bevorzugt 0,1 bis 70 Gew.-%, insbesondere 1 bis 30 Gew.-%, bezogen auf die gesamte EP/O/W-Emulsion.When the EP / O emulsion according to the invention is introduced into water or aqueous systems, the weight ratio of the individual phases can be varied within wide ranges. In the EP / O / W emulsion ultimately obtained, the weight fraction of the EP / O emulsion is preferably 0.01 to 80% by weight, particularly preferably 0.1 to 70% by weight, in particular 1 to 30% by weight. %, based on the total EP / O / W emulsion.
Beim Einbringen der erfindungsgemäßen EP/O-Emulsion in eine O/W-Emulsion beträgt der Anteil der EP/O-Emulsion vorzugsweise 0,01 bis 60 Gew.-%, besonders bevorzugt 0,1 bis 40 Gew.-%, insbesondere 1 bis 30 Gew.-%, bezogen auf die letztendlich erhaltene EP/O/W-Emulsion. 3h der O/W-Emulsion, die hierzu verwendet wird, beträgt der Ölanteil vorzugsweise 1 bis 80 Gew.-%, besonders bevorzugt 1 bis 30 Gew.-%, bezogen auf die eingesetzte O/W-Emulsion.When the EP / O emulsion according to the invention is introduced into an O / W emulsion, the proportion of the EP / O emulsion is preferably 0.01 to 60% by weight, particularly preferably 0.1 to 40% by weight, in particular 1 up to 30% by weight, based on the EP / O / W emulsion ultimately obtained. 3 hours of the O / W emulsion used for this purpose, the oil content is preferably 1 to 80% by weight, particularly preferably 1 to 30% by weight, based on the O / W emulsion used.
Die einzelnen Phasen der Emulsionen können noch übliche für die einzelnen Phasen bekannte Inhaltsstoffe aufweisen. Beispielsweise können die einzelnen Phasen weitere in diesen Phasen lösliche pharmazeutische oder kosmetische Wirkstoffe enthalten. Die wässrige Phase kann beispielsweise organische lösliche Lichtschutzfilter, hydrophil gecoatetes Mikropigment, Elektrolyte, Alkohole usw. enthalten. Einzelne oder alle der Phasen können zudem Feststoffe enthalten, die vorzugsweise ausgewählt sind aus Pigmenten oder Micropigmenten, Mikrosphären, Silikagel und ähnlichen Stoffen. Die Ölphase kann beispielsweise organisch modifizierte Tonmineralien, hydrophob gecoatete (Micro)Pigmente, organische öllösliche Lichtschutzfilter, öllösliche kosmetische Wirkstoffe, Wachse, Metallseifen wie Magnesiumstearat, Vaseline oder Gemische davon enthalten. Als (Micro)Pigmente können Titandioxid, Zinkoxid und Bariumsulfat sowie Wollastonit, Kaolin, Talk, Al2O3, Bisrnutoxidchlorid, micronisiertes Polyethylen, Glimmer, Ultramarin, Eosinfarben, Azofarbstoffe, genannt werden. Insbesondere Titandioxid oder Zinkoxid sind in der Kosmetik als Lichtschutzfilter gebräuchlich und lassen sich mittels der erfϊndungsgemäßen Emulsionen besonders glatt und gleichmäßig auf die Haut auftragen. Mikrosphären oder Silikagel können als Träger für Wirkstoffe eingesetzt werden, und Wachse können beispielsweise als Grundlage für Polituren verwendet werden.The individual phases of the emulsions can also have the usual ingredients known for the individual phases. For example, the individual phases can contain further pharmaceutical or cosmetic active ingredients that are soluble in these phases. The aqueous phase can contain, for example, organic soluble light protection filters, hydrophilically coated micropigment, electrolytes, alcohols, etc. Some or all of the phases can also contain solids, which are preferably selected from pigments or micropigments, microspheres, silica gel and similar substances. The oil phase can contain, for example, organically modified clay minerals, hydrophobically coated (micro) pigments, organic oil-soluble light protection filters, oil-soluble cosmetic active ingredients, waxes, metal soaps such as magnesium stearate, petroleum jelly or mixtures thereof. Titanium dioxide, zinc oxide and barium sulfate, as well as wollastonite, kaolin, talc, Al 2 O 3 , bisnut oxide chloride, micronized polyethylene, mica, ultramarine, eosin dyes, azo dyes, can be mentioned as (micro) pigments. In particular, titanium dioxide or zinc oxide are used in cosmetics as light protection filters and can be applied to the skin particularly smoothly and evenly by means of the emulsions according to the invention. Microspheres or silica gel can be used as carriers for active ingredients, and waxes can be used, for example, as the basis for polishes.
Die erfindungsgemäßen Esteφolyole können auch als Dispergierhilfsmittel oder kontinuierliche Phase für (Micro)Pigmentdispersionen eingesetzt werden. Derartige Systeme aus erfindungsgemäß Esteφolyolen und (Micro)Pigmenten enthalten typischerweise 10 bis 50 Gew.-% an (Micro)Pigmenten, besonders bevorzugt 35 bis 45 Gew.-% an (Micro)Pigmenten. Die aus den (Micro)Pigmenten und den Esteφolyolen erhältlichen Dispersionen können in Wasser oder in Öl eingebracht werden, ohne daß die Dispersion beeinträchtigt wird. Es ist damit durch Verwendung der Esteφolyole möglich, hydrophile Pigmente zu hydrophobieren und in eine Ölphase einzubringen, ohne dass der Dispersionsgrad sich verschlechtert. Die Erfindung betrifft damit auch eine Dispersion von (Micro)Pigmenten und/oder unlöslichen organischen Verbindungen in Esteφolyolen.The este polyols according to the invention can also be used as dispersing agents or continuous phase for (micro) pigment dispersions. Systems of this type consisting of este polyols and (micro) pigments according to the invention typically contain 10 to 50% by weight of (micro) pigments, particularly preferably 35 to 45 % By weight of (micro) pigments. The dispersions obtainable from the (micro) pigments and the este polyols can be introduced in water or in oil without the dispersion being adversely affected. It is thus possible, by using the este polyols, to make hydrophilic pigments hydrophobic and to introduce them into an oil phase without the degree of dispersion deteriorating. The invention thus also relates to a dispersion of (micro) pigments and / or insoluble organic compounds in este polyols.
Die Wasseφhase kann darüber hinaus Glycerin, Polyethylenglykol, Propylenglykol, Ethylenglykol und ähnliche Verbindungen sowie Derivate davon enthalten.The water phase can also contain glycerol, polyethylene glycol, propylene glycol, ethylene glycol and similar compounds and derivatives thereof.
In entsprechender Weise kann man auch Arzneimittel, die oral verabreicht werden, aber unter den im Magen herrschenden Bedingungen nicht stabil sind oder an anderen Orten des Verdauungstraktes zur Einwirkung kommen sollen, mit einer erfindungsgemäßen Emulsion an ihren Wirkungsort bringen. Diese Emulsion oder Dispersion wird im Magen nicht gebrochen, so daß sie den Magen unverändert passiert. Der enthaltene Wirkstoff wird daher erst nachfolgend im Verdauungstrakt freigesetzt, indem der Emulgator abgebaut oder aufgelöst wird. Die Auswahl der Emulgatoren kann dabei auf die an den Wirkorten bestehenden Bedingungen eingestellt werden.In a corresponding manner, drugs which are administered orally but which are not stable under the conditions prevailing in the stomach or which are intended to act in other places on the digestive tract can be brought to their place of action with an emulsion according to the invention. This emulsion or dispersion is not broken in the stomach, so that it passes through the stomach unchanged. The active ingredient contained is therefore only subsequently released in the digestive tract by breaking down or dissolving the emulsifier. The choice of emulsifiers can be adjusted to the conditions existing at the sites of action.
Die Verwendung von üblichen Hilfs- und Zusatzstoffen in den Emulsionen oder Dispersionen ist dem Fachmann bekannt.The skilled worker is familiar with the use of customary auxiliaries and additives in the emulsions or dispersions.
Die Herstellung der erfindungsgemäßen EP/O-Emulsionen oder -Dispersionen kann nach bekannten Verfahren erfolgen, wie sie beispielsweise in DE-A-43 41 114 und DE-A-43 41 113 beschrieben sind. Zur Herstellung werden üblicherweise die Esteφolyol/Polyolphase und die Ölphase, die jeweils Emulgator enthalten können, getrennt auf eine Temperatur im Bereich von 20 bis 90 °C erwärmt und anschließend unter Rühren zusammengegeben.The EP / O emulsions or dispersions according to the invention can be prepared by known processes, as described, for example, in DE-A-43 41 114 and DE-A-43 41 113. For the preparation, the este polyol / polyol phase and the oil phase, which can each contain emulsifier, are usually heated separately to a temperature in the range from 20 to 90 ° C. and then combined with stirring.
Die Emulsionen oder Dispersionen können in Abhängigkeit von der Zus-immensetzung, vom Phasenvolumenverhältnis und dem gegebenenfalls vorhandenen Feststoffanteil als feste oder fließfähige Emulsionen oder Dispersionen hergestellt werden und vorliegen. Es handelt sich dabei um sehr stabile Emulsionen oder Dispersionen, die unter normalen Handhabungsbedingungen eine hohe Langzeitstabilität aufweisen. Sie erfüllen insbesondere die üblichen Stabilitätsanforderungen im Temperaturbereich von -5 °C bis + 45 °C. Die in der Emulsion oder Dispersion vorliegenden Tröpfchen oder Partikel sind dabei sehr beständig, weshalb die Emulsionen oder Dispersionen insbesondere als Träger für viele Arten von Wirkstoffen geeignet sind. Die mit Hilfe der genannten Emulgatoren hergestellten Emulsionen oder Dispersionen können durch einen einfachen Mischvorgang unter Rühren erhalten werden, wobei die Stabilität der Emulsionen oder Dispersionen durch die eingetragene Rührwerksenergie und die Art des Rührwerkzeugs in der Regel kaum oder nicht beeinflusst wird. Zur Herstellung der erfindungsgemäßen Emulsion oder Dispersion kann jedes geeignete handelsübliche Rührwerk eingesetzt werden.The emulsions or dispersions can be prepared and present as solid or flowable emulsions or dispersions, depending on the composition, the phase volume ratio and the solids content which may be present. These are very stable emulsions or dispersions that have high long-term stability under normal handling conditions. In particular, they meet the usual stability requirements in the temperature range from -5 ° C to + 45 ° C. The droplets or particles present in the emulsion or dispersion are very stable, which is why the emulsions or dispersions are particularly suitable as carriers for many types of active ingredients. The emulsions or dispersions prepared with the aid of the emulsifiers mentioned can be obtained by a simple mixing process with stirring, the stability of the emulsions or dispersions generally being hardly or not influenced by the agitator energy input and the type of stirring tool. Any suitable commercially available stirrer can be used to produce the emulsion or dispersion according to the invention.
Die Erfindung betrifft auch eine Esteφθlyol-in-Öl-Dispersion, enthaltend in Öl als Dispersionsmittel Esteφolyolteilchen, die sich von Glycerin, Ethylenglykol, Polyethylenglykol, in dem bis zu 30% der Ethylenoxyeinheiten durch Propylenoxyeinheiten ersetzt sein können, als Polyolkomponente und aliphatischen C3_6- Carbonsäuren, die neben einer Carboxylgruppe mindestens eine weitere funktionelle Gruppe, ausgewählt aus Hydroxyl- und Carboxylgruppen, aufweisen, als Säurekomponente ableiten, die bei 25°C fest oder glasartig vorliegen, mit einer mittleren Teilchengröße im Bereich von 10 bis 10.000 nm, mindestens einen Emulgator, der Lamellarstrukturen ausbildet, wobei die Esteφolyolteilchen einen in der Phase gelösten oder dispergierten pharmazeutischen, kosmetischen, Waschmittel-technologischen, lebensmitteltechnologischen und/oder agrartechnologischen Wirkstoff enthalten können.The invention also relates to an Esteφθlyol-in-oil dispersion containing Esteφolyolparticles in oil as a dispersant, which are derived from glycerol, ethylene glycol, polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, as a polyol component and aliphatic C 3 _ 6 - carboxylic acids, which in addition to a carboxyl group have at least one further functional group selected from hydroxyl and carboxyl groups, are derived as acid components which are solid or glassy at 25 ° C., with an average particle size in the range from 10 to 10,000 nm, at least an emulsifier which forms lamellar structures, the estepolyol particles being able to contain a pharmaceutical, cosmetic, detergent-technological, food-technological and / or agricultural-technological active ingredient dissolved or dispersed in the phase.
Bei dieser Dispersion handelt es sich insbesondere um eine SPN-Dispersion (solid polyol nanoparticles) analog einer SLN-Dispersion (solid lipid nanoparticles), wobei die Lipidphase durch die erfindungsgemäß eingesetzten festen Esteφolyole ganz oder teilweise ersetzt ist und in Öl statt Wasser gearbeitet wird. Der Aufbau und die Herstellung der erfindungsgemäßen SPN-Dispersion ist beispielsweise in EP-B 0 605 497 und EP-B 0 167 825 beschrieben. Die Herstellung der Dispersion kann wie dort beschrieben erfolgen, und die Dispersion kann die beschriebenen pharmazeutisch aktiven Substanzen enthalten.This dispersion is in particular an SPN dispersion (solid polyol nanoparticles) analogous to an SLN dispersion (solid lipid nanoparticles), the lipid phase being replaced in whole or in part by the solid este polyols used in accordance with the invention and working in oil instead of water. The structure and production of the SPN dispersion according to the invention is described, for example, in EP-B 0 605 497 and EP-B 0 167 825. The dispersion can be prepared as described there, and the dispersion can contain the pharmaceutically active substances described.
Gemäß einer Ausführungsform der Erfindung erfolgt die Herstellung der Dispersion durch mechanisches Vermischen der Esteφolyolphase mit einer Ölphase bei einer Temperatur oberhalb des Schmelz- oder Erweichungspunktes des Esteφolyols, wobei das Gewichtsverhältnis von Esteφolyolphase zu Ölphase 1:5 bis 5:1, vorzugsweise 2:1 bis 1:2 beträgt. Die Vermischung erfolgt dabei vorzugsweise ohne Hochdrackhomogemsierung unter Einsatz von Rührern, in denen die Scherwirkung der Scherwirkung eines Haushaltsrührers entspricht. Die so erhaltene Mischphase kann sodann mit Öl weiter verdünnt werden, bis ein gewünschter Dispersionsgrad erreicht wird. Für die Herstellung der Dispersion geeignete Emulgatoren sind wiederum in EP-B 0 605 497 oder EP-B 0 167 825 beschrieben. Der mittlere Teilchendurchmesser in der festen Esteφolyolphase beträgt vorzugsweise 40 bis 1000 nm. Die Ölphase kann die für SPN-Dispersion üblichen Additive enthalten wie Gelbildner, Cross-Polymere, Cellulosederivate, Xanthangumen, Gelatine oder Pectine. Weitere Inhaltsstoffe sind dem Fachmann bekannt.According to one embodiment of the invention, the dispersion is produced by mechanical mixing of the este polyol phase with an oil phase at a temperature above the melting or softening point of the este polyol, the weight ratio of este polyol phase to oil phase being 1: 5 to 5: 1, preferably 2: 1 to Is 1: 2. The mixing is preferably carried out without high-pressure homogenization using stirrers in which the shear effect corresponds to the shear effect of a household stirrer. The mixed phase thus obtained can then be further diluted with oil until a desired degree of dispersion is achieved. Emulsifiers suitable for the preparation of the dispersion are again described in EP-B 0 605 497 or EP-B 0 167 825. The average particle diameter in the solid ester polyol phase is preferably 40 to 1000 nm. The oil phase can contain the additives customary for SPN dispersion, such as gel formers, cross-polymers, cellulose derivatives, xanthan gum, gelatin or pectins. Other ingredients are known to the person skilled in the art.
Die erfindungsgemäßen Emulsionen oder Dispersionen werden bevorzugt in kosmetischen und/oder pharmazeutischen und/oder Agrowirkstoff-Zusammensetzungen verwendet. Damit betrifft die Erfindung auch derartige kosmetische und/oder pharmazeutische und/oder Agrowirkstoff-Zusarnmensetzungen, die mindestens eine der genannten Emulsionen enthalten. Bei den kosmetischen und/oder pharmazeutischen Zusammensetzungen kann es sich um Hand- oder Köφerlotionen, Öle, Salben, Pasten, Gele, Lippenpflegeprodukte, Gesichtspflegeprodukte und ähnliche Zusammensetzungen handeln. Die Zusammensetzungen können dabei in fester, flüssiger oder Aerosolform zum Einsatz kommen.The emulsions or dispersions according to the invention are preferably used in cosmetic and / or pharmaceutical and / or active ingredient compositions. The invention thus also relates to such cosmetic and / or pharmaceutical and / or agro-active substance compositions which contain at least one of the emulsions mentioned. The cosmetic and / or pharmaceutical compositions can be hand or body lotions, oils, ointments, pastes, gels, lip care products, face care products and similar compositions. The compositions can be used in solid, liquid or aerosol form.
Die Erfindung betrifft femer die Verwendung der Esteφolyole als Lösungsmittel, Lösungsvermittler oder Dispergierhilfsmittel für in lipophilen und hydrophilen Medien gering lösliche (< 10% Löslichkeit) oder unlösliche organische Verbindungen. Geeignete Moleküle oder Molekülgruppen sind beispielsweise Salicylsäure, Sphingosine, Ceramide, Triteφensäure wie Oleanolinsäure, Betulinsäure, Betulin, Ursolsäure, Boswelliasäure, 18- ß-Glycyrrhetinsäure, Forskolin, Sclareolid, Andrographolide.The invention further relates to the use of este polyols as solvents, solubilizers or dispersants for slightly soluble (<10% solubility) or insoluble organic compounds in lipophilic and hydrophilic media. Suitable molecules or groups of molecules are, for example, salicylic acid, sphingosines, ceramides, triteφenic acid such as oleanolic acid, betulinic acid, betulin, ursolic acid, boswellic acid, 18-ß-glycyrrhetic acid, forskolin, sclareolide, andrographolides.
Geeignet sind femer Gesamtextrakte aus Pflanzen, die u.a. obige Moleküle oder Molekülklassen enthalten.Also suitable are total extracts from plants that include contain the above molecules or classes of molecules.
Als lipophile Medien kommen dabei die vorstehend genannten Öle in Betracht, als hydrophile Medien wässrige Medien mit einem Wasseranteil von mindestens 80, vorzugsweise mindestens 90, insbesondere mindestens 95 Gew.-%. Als unlöslich werden Verbindungen angesehen, deren Löslichkeit unter 3%, vorzugsweise unter 1%, insbesondere unter 0,5% liegt.The oils mentioned above can be considered as lipophilic media and aqueous media with a water content of at least 80, preferably at least 90, in particular at least 95% by weight as hydrophilic media. Compounds whose solubility is below 3%, preferably below 1%, in particular below 0.5%, are regarded as insoluble.
Die Erfindung betrifft auch eine Lösung von in lipophilen und hydrophilen Medien unlöslichen organischen Verbindungen in Esteφolyolen, die wie vorstehend definiert aufgebaut sind.The invention also relates to a solution of organic compounds insoluble in lipophilic and hydrophilic media in este polyols, which are structured as defined above.
Femer betrifft die Erfindung die Verwendung von Esteφolyolen als Lösungsvermittler zum Einbringen von kosmetischen und/oder pharmazeutischen und/oder Agro- Wirkstoffen in Polyol-in-Öl-Emulsionen oder Polyol-in-Öl-in- Wasser-Emulsionen oder entsprechende Dispersionen. Die erfindungsgemäßen Emulsionen oder Dispersionen können für die darin enthaltenen Wirkstoffe eine Transport- und eine Depotwirkung zeigen. Sie können damit nicht nur als Carrier sondern auch als Depots wirken, die über einen bestimmen Zeitraum eine verzögerte Freisetzung des Wirkstoffs erlauben.The invention further relates to the use of este polyols as solubilizers for introducing cosmetic and / or pharmaceutical and / or agroactive ingredients into polyol-in-oil emulsions or polyol-in-oil-in-water emulsions or corresponding dispersions. The emulsions or dispersions according to the invention can have a transport and a depot effect for the active substances contained therein. They can not only act as carriers but also as depots, which allow a delayed release of the active ingredient over a certain period of time.
Die erfindungsgemäßen Emulsionen oder Dispersionen zeigen die folgenden Vorteile:The emulsions or dispersions according to the invention have the following advantages:
Oxidationsempfindliche und hydrolyseempfindliche Wirkstoffe können stabil und insbesondere über einen längeren Zeitraum lagerstabil verkapselt werden. Der Feuchtigkeitsangriff auf die Wirkstoffe kann mit den erfindungsgemäßen Emulsionen und Dispersionen zuverlässig verhindert werden.Active substances which are sensitive to oxidation and sensitive to hydrolysis can be encapsulated in a stable manner and in particular in a stable manner over a longer period of time. The emulsions and dispersions according to the invention can reliably prevent moisture attack on the active ingredients.
In hydrophilen und lipophilen Medien unlösliche Wirkstoffe können in Form einer Emulsion bzw. Dispersion dargereicht werden.Active ingredients which are insoluble in hydrophilic and lipophilic media can be administered in the form of an emulsion or dispersion.
Die Penetrationseigenschaften der kosmetischen oder pharmazeutischen Zusammensetzungen können durch Einsatz der erfindungsgemäßen Emulsionen positiv beeinflußt werden. Insbesondere in den beschriebenen multiplen Emulsionen können eine Depotwirkung und eine verbesserte Penetration erreicht werden.The penetration properties of the cosmetic or pharmaceutical compositions can be positively influenced by using the emulsions according to the invention. A depot effect and improved penetration can be achieved in particular in the multiple emulsions described.
Die Überwindung der Hautpermeabilitätsbarriere wird dadurch erreicht, daß durch Ausbildung flüssigkristalliner Gel-Netzwerkstrukturen in den beschriebenen multiplen Emulsionen ein Ordnungszustand aufgebaut wird, der dem der Lipidbarriere der Haut entspricht. In einem derartigen Trägersystem werden die Penetrationseigenschaften der genannten pharmakologischen und kosmetischen Wirkstoffe entscheidend verbessert. Gleiches gilt für die Dispersionen.The skin permeability barrier is overcome in that by forming liquid-crystalline gel network structures in the multiple emulsions described, an order is established which corresponds to that of the lipid barrier of the skin. In such a carrier system, the penetration properties of the pharmacological and cosmetic active ingredients mentioned are decisively improved. The same applies to the dispersions.
Die Erfindung wird durch die nachstehenden Beispiele näher erläutert.The invention is illustrated by the examples below.
BeispieleExamples
Figure imgf000017_0001
Figure imgf000018_0001
Figure imgf000017_0001
Figure imgf000018_0001
Beispiel 1example 1
Phase APhase A
DGCL-Citrate 30.00DGCL Citrate 30.00
GLC-Lactate 30.00GLC lactates 30.00
Ascorbinsäure 10.00Ascorbic acid 10.00
Phase BPhase B
Dow Coming DC 5225 C Formulation Aid 15.00Dow Coming DC 5225 C Formulation Aid 15.00
Abil EM 97 10.00Abil EM 97 10.00
Wacker Belsil CM 040 5.00 total 100.00Wacker Belsil CM 040 5.00 total 100.00
Herstellung:production:
Phasen A und B getrennt auf 65°C erwärmen;Heat phases A and B separately to 65 ° C;
Phase A solange rühren, bis die Ascorbinsäure gelöst ist;Stir phase A until the ascorbic acid is dissolved;
Phase A langsam unter Rühren in Phase B geben;Add phase A slowly to phase B while stirring;
Homogenisieren, bis eine Tröpfchengröße unterhalb 450 nm erreicht ist;Homogenize until a droplet size below 450 nm is reached;
Ansatz auf Raumtemperatur abkühlen.Cool the batch to room temperature.
Beispiel 2Example 2
Phase APhase A
PEG 6000 15.00PEG 6000 15.00
Glycerinlactat 40.00Glycerol lactate 40.00
Ascorbinsäure 10.00 Phase BAscorbic acid 10.00 Phase B
Dow Corning DC 5225 C Formulation Aid 15.00Dow Corning DC 5225 C Formulation Aid 15.00
Abil EM 97 10.00Abil EM 97 10.00
Wacker Belsil CM 040 10.00 total 100.00Wacker Belsil CM 040 10.00 total 100.00
Herstellung:production:
Phasen A und B getrennt auf 65°C erwärmen;Heat phases A and B separately to 65 ° C;
Phase A solange rühren, bis die Ascorbinsäure gelöst ist;Stir phase A until the ascorbic acid is dissolved;
Phase A langsam unter Rühren in Phase B geben;Add phase A slowly to phase B while stirring;
Homogenisieren, bis eine Tröpfchengröße unterhalb 450 nm erreicht ist;Homogenize until a droplet size below 450 nm is reached;
Ansatz auf Raumtemperatur abkühlen.Cool the batch to room temperature.
Beispiel 3Example 3
Phase APhase A
PEG 6000 40.00 Retinol 5.00 Polysorbat 20 5.00PEG 6000 40.00 retinol 5.00 polysorbate 20 5.00
Phase BPhase B
Dow Corning DC 5225 C Formulation Aid 25.00
Figure imgf000019_0001
Dow Corning DC 5225 C Formulation Aid 25.00
Figure imgf000019_0001
Wacker Belsil CM 040 15.00 total 100.00Wacker Belsil CM 040 15.00 total 100.00
Herstellung:production:
Phasen A und B getrennt auf 65°C erwärmen;Heat phases A and B separately to 65 ° C;
Phase A solange rühren, bis das Retinol gelöst ist;Stir phase A until the retinol is dissolved;
Phase A langsam unter Rühren in Phase B geben;Add phase A slowly to phase B while stirring;
Homogenisieren, bis eine Tröpfchengröße unterhalb 450 nm erreicht ist;Homogenize until a droplet size below 450 nm is reached;
Ansatz auf Raumtemperatur abkühlen. Beispiel 4Cool the batch to room temperature. Example 4
Phase APhase A
DGCL-Citrate 25.00DGCL Citrate 25.00
GLC-Lactate 35.00GLC lactates 35.00
Polyphenole 10.00Polyphenols 10.00
Phase BPhase B
Dow Corning DC 5225 C Formulation Aid 15.00Dow Corning DC 5225 C Formulation Aid 15.00
Abil EM 97 10.00Abil EM 97 10.00
Wacker Belsil CM 040 * 5.00 total 100.00Wacker Belsil CM 040 * 5.00 total 100.00
Herstellung:production:
Phasen A und B getrennt auf 65°C erwärmen;Heat phases A and B separately to 65 ° C;
Phase A solange rühren, bis das Polyphenol gelöst ist;Stir phase A until the polyphenol is dissolved;
Phase A langsam unter Rühren in Phase B geben;Add phase A slowly to phase B while stirring;
Homogenisieren, bis eine Tropf chengröße unterhalb 450 nm erreicht ist;Homogenize until a droplet size below 450 nm is reached;
Ansatz auf Raumtemperatur abkühlen. Cool the batch to room temperature.

Claims

Patentansprücheclaims
1. Verwendung von Esteφolyolen, die sich von1. Use of Esteφolyolen, which differs from
Glycerin, C2-20-Alkylenglykol, Poly(C2_20-alkylen)glykol, vorzugsweise Ethylenglykol, Polyethylenglykol, in dem bis zu 30% der Ethylenoxyeinheiten durch Propylenoxyeinheiten ersetzt sein können, Polyglycerinen, Sorbitol, Pentaerythritol, als Polyolkomponente undGlycerin, C 2-20 alkylene glycol, poly (C 2 _ 20 alkylene) glycol, preferably ethylene glycol, polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, polyglycerols, sorbitol, pentaerythritol, as the polyol component and
aliphatischen C3-6-Carbonsäuren, die neben einer Carboxylgruppe mindestens eine weitere funktionelle Gruppe, ausgewählt aus Hydroxyl- und Carboxylgruppen, aufweisen, als Säurekomponentealiphatic C 3-6 carboxylic acids which, in addition to a carboxyl group, have at least one further functional group selected from hydroxyl and carboxyl groups, as the acid component
ableiten, oder Gemischen der Esteφolyole mit aminofunktionellen Polyolen mit einem Schmelzpunkt von weniger als 100°C oder Esteφolyolen der allgemeinen Formel (I)derive, or mixtures of the este polyols with amino-functional polyols with a melting point of less than 100 ° C. or este polyols of the general formula (I)
Figure imgf000021_0001
Figure imgf000021_0001
(I)(I)
mit der Bedeutungwith the meaning
R1 C1-4-Alkyl,R 1 C 1-4 alkyl,
R2 Wasserstoff oder C1-4-Alkyl, n im Mittel I bis 100, m im Mittel 0 bis n/2R 2 is hydrogen or C 1-4 alkyl, n on average I to 100, m on average 0 to n / 2
EO, PO von Ethylenoxid und Propylenoxid abgeleitete Grundbausteine, die beim Vorliegen beider Grundbausteine in beliebiger Reihenfolge vorliegen können,EO, PO basic building blocks derived from ethylene oxide and propylene oxide, which can exist in any order if both basic building blocks are present,
als Lösungsmittel, Lösungsvermittler oder Dispergierhilfsmittel für in lipophilen und hydrophilen Medien unzureichend lösliche oder unlösliche organische Verbindungen, pharmazeutische, kosmetische, waschmitteltechnologische, lebensmitteltechnologische oder agrartechnologische Wirkstoffe und als Dispergierhilfsmittel oder kontinuierliche Phase für (Micro)pigment-Dispersionen.as solvents, solubilizers or dispersing agents for organic compounds which are insufficiently soluble or insoluble in lipophilic and hydrophilic media, pharmaceutical, cosmetic, detergent technology, active ingredients in food technology or agricultural technology and as a dispersing aid or continuous phase for (micro) pigment dispersions.
Lösung von in lipophilen und hydrophilen Medien unzureichend löslichen oder unlöslichen organischen Verbindungen in Esteφolyolen, die sich vonSolution of inadequately soluble or insoluble organic compounds in lipophilic and hydrophilic media in este polyols, which differ from
Glycerin, Ethylenglykol, Polyethylenglykol, in dem bis zu 30% der Ethylenoxyeinheiten durch Propylenoxyeinheiten ersetzt sein können, als Polyolkomponente undGlycerin, ethylene glycol, polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, as the polyol component and
aliphatischen C -6-Carbonsäuren, die neben einer Carboxylgruppe mindestens eine weitere funktionelle Gruppe, ausgewählt aus Hydroxyl- und Carboxylgruppen, aufweisen, als Säurekomponentealiphatic C -6- carboxylic acids which, in addition to a carboxyl group, have at least one further functional group selected from hydroxyl and carboxyl groups, as the acid component
ableiten, oder Gemischen der Esteφolyole mit aminofunktionellen Polyolen mit einem Schmelzpunkt von weniger als 100°C oder Esteφolyolen der allgemeinen Formel (I)derive, or mixtures of the este polyols with amino-functional polyols with a melting point of less than 100 ° C. or este polyols of the general formula (I)
Figure imgf000022_0001
Figure imgf000022_0001
(I)(I)
mit der Bedeutungwith the meaning
R1 C^-Alkyl,R 1 C ^ alkyl,
R2 Wasserstoff oder C1- -Alkyl, n im Mittel I bis 100, m im Mittel 0 bis n/2R 2 is hydrogen or C 1- alkyl, n on average I to 100, m on average 0 to n / 2
EO, PO von Ethylenoxid und Propylenoxid abgeleitete Grundbausteine, die beim Vorliegen beider Grundbausteine in beliebiger Reihenfolge vorliegen können.EO, PO basic building blocks derived from ethylene oxide and propylene oxide, which can be present in any order if both basic building blocks are present.
3. Dispersion von (Micro)Pigmenten und/oder unlöslichen organischen Verbindungen in Esteφolyolen, die sich von Glycerin, Ethylenglykol, Polyethylenglykol, in dem bis zu 30% der Ethylenoxyeinheiten durch Propylenoxyeinheiten ersetzt sein können, als Polyolkomponente und3. Dispersion of (micro) pigments and / or insoluble organic compounds in este polyols, which differ from Glycerin, ethylene glycol, polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, as the polyol component and
aliphatischen C3-6-Carbonsäuren, die neben einer Carboxylgruppe mindestens eine weitere funktionelle Gruppe, ausgewählt aus Hydroxyl- und Carboxylgruppen, aufweisen, als Säurekomponentealiphatic C 3-6 carboxylic acids which, in addition to a carboxyl group, have at least one further functional group selected from hydroxyl and carboxyl groups, as the acid component
ableiten, oder Gemischen der Esteφolyole mit aminofunktionellen Polyolen mit einem Schmelzpunkt von weniger als 100°C oder Esteφolyolen der allgemeinen Formel (I)derive, or mixtures of the este polyols with amino-functional polyols with a melting point of less than 100 ° C. or este polyols of the general formula (I)
Figure imgf000023_0001
Figure imgf000023_0001
(I)(I)
mit der Bedeutungwith the meaning
R1 C -Alkyl,R 1 C alkyl,
R2 Wasserstoff oder C1-4-Alkyl, n im Mittel 1 bis 100, m im Mittel 0 bis n/2R 2 is hydrogen or C 1-4 alkyl, n on average 1 to 100, m on average 0 to n / 2
EO, PO von Ethylenoxid und Propylenoxid abgeleitete Grundbausteine, die beim Vorliegen beider Grundbausteine in beliebiger Reihenfolge vorliegen können.EO, PO basic building blocks derived from ethylene oxide and propylene oxide, which can be present in any order if both basic building blocks are present.
Verwendung von Esteφolyolen, die sich vonUse of este polyols that differ from
Glycerin, Ethylenglykol, Polyethylenglykol, in dem bis zu 30% der Ethylenoxyeinheiten durch Propylenoxyeinheiten ersetzt sein können, als Polyolkomponente undGlycerin, ethylene glycol, polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, as the polyol component and
aliphatischen C -6-Carbonsäuren, die neben einer Carboxylgruppe mindestens eine weitere funktionelle Gruppe, ausgewählt aus Hydroxyl- und Carboxylgruppen, aufweisen, als Säurekomponente ableiten, oder Gemischen der Esteφolyole mit aminofunktionellen Polyolen mit einem Schmelzpunkt von weniger als 100°C oder Esteφolyolen der allgemeinen Formel (I)aliphatic C -6- carboxylic acids which, in addition to a carboxyl group, have at least one further functional group selected from hydroxyl and carboxyl groups, as the acid component derive, or mixtures of the este polyols with amino-functional polyols with a melting point of less than 100 ° C. or este polyols of the general formula (I)
Figure imgf000024_0001
Figure imgf000024_0001
(I)(I)
mit der Bedeutungwith the meaning
R1 C1-4-Alkyl,R 1 C 1-4 alkyl,
R2 Wasserstoff oder C1-4-Alkyl, n im Mittel I bis 100, m im Mittel 0 bis n/2R 2 is hydrogen or C 1-4 alkyl, n on average I to 100, m on average 0 to n / 2
EO, PO von Ethylenoxid und Propylenoxid abgeleitete Grundbausteine, die beim Vorliegen beider Grundbausteine in beliebiger Reihenfolge vorliegen können,EO, PO basic building blocks derived from ethylene oxide and propylene oxide, which can exist in any order if both basic building blocks are present,
als Lösungsvermittler zum Einbringen von kosmetischen und/oder pharmazeutischen und/oder waschmitteltechnologischen und/oder lebensmitteltechnologischen und/oder agrartechnologischen Wirkstoffen in Polyol-in-Öl- Emulsionen oder -Dispersionen oder Polyol-in-Öl-in- Wasser-Emulsionen oder - Dispersionen.as a solubilizer for the introduction of cosmetic and / or pharmaceutical and / or detergent technology and / or food technology and / or agricultural technology active ingredients in polyol-in-oil emulsions or dispersions or polyol-in-oil-in-water emulsions or dispersions.
5. Esteφolyol/Polyol-in-Öl-Emulsion oder -Dispersion, enthaltend Esteφolyole, die sich von5. Esteφolyol / polyol-in-oil emulsion or dispersion containing Esteφolyols, which is different from
Glycerin, Ethylenglykol, Polyethylenglykol, in dem bis zu 30% der Ethylenoxyeinheiten durch Propylenoxyeinheiten ersetzt sein können, als Polyolkomponente undGlycerin, ethylene glycol, polyethylene glycol, in which up to 30% of the ethyleneoxy units can be replaced by propyleneoxy units, as the polyol component and
aliphatischen C3-6-Carbonsäuren, die neben einer Carboxylgruppe mindestens eine weitere funktionelle Gruppe, ausgewählt aus Hydroxyl- und Carboxylgruppen, aufweisen, als Säurekomponente ableiten, oder Gemischen der Esteφolyole mit aminofunktionellen Polyolen mit einem Schmelzpunkt von weniger als 100°C oder Esteφolyolen der allgemeinen Formel (I)aliphatic C 3-6 carboxylic acids which, in addition to a carboxyl group, have at least one further functional group selected from hydroxyl and carboxyl groups, as the acid component derive, or mixtures of the este polyols with amino-functional polyols with a melting point of less than 100 ° C. or este polyols of the general formula (I)
R^O-fEO-UPO-jmR2 R ^ O-fEO-UPO-j m R 2
(I)(I)
mit der Bedeutungwith the meaning
R1 Cι- -AIkyl,R 1 Cι -alkyl,
R2 Wasserstoff oder Cι-4-Alkyl, n im Mittel I bis 100, m im Mittel 0 bis n/2R 2 is hydrogen or C 4 alkyl, n on average I to 100, m on average 0 to n / 2
EO, PO von Ethylenoxid und Propylenoxid abgeleitete Grundbausteine, die beim Vorliegen beider Grundbausteine in beliebiger Reihenfolge vorliegen können,EO, PO basic building blocks derived from ethylene oxide and propylene oxide, which can exist in any order if both basic building blocks are present,
in einer mit Öl nicht mischbaren Esteφolyol/Polyolphase, eine Ölphase und mindestens einen Emulgator.in an esterspolyol / polyol phase immiscible with oil, an oil phase and at least one emulsifier.
6. Emulsion oder Dispersion nach Anspruch 5, dadurch gekennzeichnet, daß als Säurekomponente in den Esteφolyolen Milchsäure, Maleinsäure, Weinsäure oder Citronensäure eingesetzt werden.6. Emulsion or dispersion according to claim 5, characterized in that lactic acid, maleic acid, tartaric acid or citric acid are used as the acid component in the este polyols.
7. Emulsion oder Dispersion nach Anspruch 6, dadurch gekennzeichnet, daß die Esteφolyole bei 25 °C fest oder glasartig vorliegen und eine mittlere Teilchengröße im Bereich von 10 bis 10.000 nm aufweisen können.7. emulsion or dispersion according to claim 6, characterized in that the este polyols are solid or glassy at 25 ° C and may have an average particle size in the range of 10 to 10,000 nm.
8. Emulsion oder Dispersion nach einem der Ansprüche 5 bis 7, dadurch gekennzeichnet, dass in der Esteφolyol/Polyolphase mindestens 50 Gew.-% Esteφolyol vorliegen.8. Emulsion or dispersion according to one of claims 5 to 7, characterized in that there are at least 50% by weight of este polyol in the este polyol / polyol phase.
9. Emulsion oder Dispersion nach einem der Ansprüche 5 bis 8, dadurch gekennzeichnet, dass die Esteφolyol/Polyolphase einen in der Phase gelösten kosmetischen und/oder pharmazeutischen und/oder waschmitteltechnologischen und/oder lebensmitteltechnologischen und/oder agrartechnologischen Wirkstoff enthält.9. Emulsion or dispersion according to one of claims 5 to 8, characterized in that the Esteφolyol / polyol phase a cosmetic and / or pharmaceutical and / or detergent technology dissolved in the phase and / or contains food technology and / or agricultural technology active ingredient.
10. Verfahren zur Herstellung von Emulsionen oder Dispersionen nach einem der Ansprüche 5 bis 9, dadurch gekennzeichnet, dass die Esteφolyol/Polyolphase und die Ölphase, die jeweils Emulgator enthalten kömien, getrennt auf eine Temperatur im Bereich von 20 bis 90°C erwärmt und anschließend unter Rühren zusammengegeben werden.10. A process for the preparation of emulsions or dispersions according to any one of claims 5 to 9, characterized in that the Esteφolyol / polyol phase and the oil phase, each of which may contain emulsifier, heated separately to a temperature in the range from 20 to 90 ° C and then can be combined with stirring.
11. Esteφolyol/Polyol-in-Öl-in- Wasser-Emulsion oder -Dispersion, enthaltend mindestens eine Emulsion oder Dispersion gemäß einem der Ansprüche 5 bis 9 und zusätzlich mindestens eine wässrige Phase.11. Esteφolyol / polyol-in-oil-in-water emulsion or dispersion, containing at least one emulsion or dispersion according to one of claims 5 to 9 and additionally at least one aqueous phase.
12. Verwendung von Emulsionen oder Dispersionen gemäß einem der Ansprüche 5 bis 9 oder 11 in kosmetischen und/oder pharmazeutischen und/oder waschmitteltechnologischen und/oder lebensmitteltechnologischen und/oder agrartechnologischen Wirkstoff-Zusammensetzungen.12. Use of emulsions or dispersions according to one of claims 5 to 9 or 11 in cosmetic and / or pharmaceutical and / or detergent technology and / or food technology and / or agricultural technology active ingredient compositions.
13. Kosmetische und/oder pharmazeutische und/oder waschmitteltechnologische und/oder lebensmitteltechnologische und/oder agrartechnologische Wirkstoff- Zusammensetzung, enthaltend mindestens eine Emulsion oder Dispersion gemäß einem der Ansprüche 5 bis 9 oder 11. 13. Cosmetic and / or pharmaceutical and / or detergent technology and / or food technology and / or agricultural technology active ingredient composition, comprising at least one emulsion or dispersion according to one of claims 5 to 9 or 11.
PCT/EP2004/002385 2003-03-11 2004-03-08 Ester polyols as solvents, and emulsions and dispersions containing the same WO2004080582A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10310523.9 2003-03-11
DE10310523A DE10310523A1 (en) 2003-03-11 2003-03-11 Use of ester polyol compounds as solvents, or solvent or dispersion aids in production of emulsions or dispersions containing organic compounds, pigments or pharmaceuticals, cosmetics, detergents, food or agrochemical agents

Publications (2)

Publication Number Publication Date
WO2004080582A2 true WO2004080582A2 (en) 2004-09-23
WO2004080582A3 WO2004080582A3 (en) 2004-11-11

Family

ID=32892026

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/002385 WO2004080582A2 (en) 2003-03-11 2004-03-08 Ester polyols as solvents, and emulsions and dispersions containing the same

Country Status (2)

Country Link
DE (1) DE10310523A1 (en)
WO (1) WO2004080582A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2747936C (en) 2008-12-22 2017-04-25 Henkel Ag & Co. Kgaa Water-based cleaner for cleaning solvent-based paints
US10287448B2 (en) * 2016-07-08 2019-05-14 Evonik Degussa Gmbh Universal pigment preparation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953393A (en) * 1974-01-07 1976-04-27 Basf Wyandotte Corporation Low temperature process for the preparation of graft copolymer dispersions
US4410687A (en) * 1982-11-29 1983-10-18 Ppg Industries, Inc. Polyester dispersants for coating compositions
US20030013763A1 (en) * 2000-07-12 2003-01-16 Brooks George A. Glycerol-lactate esters for use as an energy supplement during exercise and recovery

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953393A (en) * 1974-01-07 1976-04-27 Basf Wyandotte Corporation Low temperature process for the preparation of graft copolymer dispersions
US4410687A (en) * 1982-11-29 1983-10-18 Ppg Industries, Inc. Polyester dispersants for coating compositions
US20030013763A1 (en) * 2000-07-12 2003-01-16 Brooks George A. Glycerol-lactate esters for use as an energy supplement during exercise and recovery

Also Published As

Publication number Publication date
WO2004080582A3 (en) 2004-11-11
DE10310523A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
EP1628626B2 (en) Compositions for the targetted release of fragrances and aromas
EP0582245B1 (en) Bath additive composition
EP0582246B1 (en) Mixture of polyglycerine fatty acids esters
EP1773283B1 (en) Highly concentrated self-emulsifying emulsion bases used for the production of oil-in-water emulsions
DE602005001478T2 (en) Oil-in-water emulsified composition
EP1347734B1 (en) Vesicle forming skin oil containing w/o-emulsifiers with a hydrophilic-lipophilic balance of 2-5.9, method for the production and use thereof
EP1891935A1 (en) Emulsion concentrate
EP2739137B1 (en) Use of isosorbide monoesters as thickeners
DE19930438A1 (en) Cosmetic agent with separate perfume oil and carrier phases to improve stability of the perfume oil during storage
DE69519952T2 (en) Self-tanning cosmetic products containing dihydroxyacetone
WO2002047641A2 (en) Skin oils consisting of oil-soluble constituents
EP1631246B1 (en) Titanium dioxide and methylene-bis-benzotriazolyl-phenol mixture
WO2004080582A2 (en) Ester polyols as solvents, and emulsions and dispersions containing the same
DE10226201A1 (en) Ether alcohols as solvents and emulsions and dispersions containing them
EP0813861A2 (en) Sunscreen compositions in the form of oil-in-water microemulsions
EP2111850B1 (en) Use of citric acid esters as W/O emulgators
EP1631628B1 (en) Inorganic light-absorbing micropigments and the use thereof
EP0986364B1 (en) Multiple water/oil/water emulsions with a high polyol content
EP1485194A1 (en) P/o emulsions comprising aminofunctional polyols
DE2646435B2 (en) Process for the production of a stable oil-in-water emulsion
EP0784972A2 (en) Cosmetic and/or pharmaceutical emulsions
EP2651373B1 (en) Liposome-forming aqueous bath preparations having a high proportion of active substance and use of said preparations
EP2111851B1 (en) Emulgator mixture
DE102011077042A1 (en) Hair cosmetic preparations comprising polyglyceryl-10-stearate
DE29520816U1 (en) Cosmetic and / or pharmaceutical emulsions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase